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Part A. Asymmetric Total Synthesis of (–)-Penibruguieramine A  
Using Memory of Chirality and Dynamic Kinetic Resolution. 
 
(–)-Penibruguieramine A is a novel marine pyrrolizidine alkaloid, which was 
recently identified by Guo from the endophytic fungus Penicillium sp. GD6 
associated with Chinese mangroves. This natural product has an unprecedented 1-
hydroxyl-2-methyl pyrrolizidin-3-one skeleton.  
We have achieved the first total synthesis of this marine alkaloid using the 
principles of ‘memory of chirality (MOC)’ and ‘dynamic kinetic resolution (DKR)’ 
for the asymmetric synthesis from proline as the only chiral source. MOC and 
DKR are attractive strategies for asymmetric synthesis. However, although there 
have been reports of DKR being utilized, there are only few reports of MOC being 
applied in total synthesis of natural products. Moreover, the combination of these 
two concepts has not been previously reported for asymmetric synthesis. 
Our synthesis follows the proposed biosynthetic pathway and features an 
asymmetric construction of stereocenters with essentially complete diastereo- and 
enantioselectivity in the absence of external chiral sources. Noteworthy is the 
excellent level of memory of chirality in a protic solvent environment. To 
understand this, we performed some experiments and provided a mechanistic 
rationale 
 
Key word: Aldol reaction, Biomimetic synthesis, Dynamic kinetic resolution, 
Memory of chirality, Total synthesis 





Part B. Biphasic CuAAC Reaction Using a Phase Transfer Agent. 
 
A phase transfer agent assisted biphasic Cu(I) catalyzed azide-alkyne 1,3-
dipolar cycloaddition (CuAAC) reaction system was developed. A biphasic 
reaction media consisting of water and an organic solvent ensures a dissolution of 
reagents and substrates. Tris(triazolylmethyl)amine ligands with an appropriate 
hydrophilic-lipophilic balance are able to extract copper from the aqueous phase to 
the organic phase, accelerating the CuAAC reaction rate. The present system is 
widely applicable to substrates with various functionalities, including a free amino 
group and especially to lipophilic substrates. 
 
Key word: Click chemistry, Ligand effect, Phase transfer agent, Solvent effect, 
Synthetic method 
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Asymmetric Total Synthesis of  
(–)-Penibruguieramine A  






(–)-Penibruguieramine A (1, Scheme 1) is a novel marine pyrrolizidine alkaloid, 
which was recently identified by Guo and co-workers from the endophytic fungus 
Penicillium sp. GD6 associated with Chinese mangroves.
1
 The relative 
configuration of 1 was established by rotating-frame Overhauser effect 
spectroscopy (ROESY) analysis, and its absolute configuration was determined by 
comparison of the electronic circular dichroism (ECD) spectra with the calculated 
ECD data. This natural product has an unprecedented 1-hydroxyl-2-methyl 
pyrrolizidin-3-one skeleton bearing an alkenyl chain at the C-1 position and a 
hydroxymethyl group at the C-8 position.  
 
Scheme 1. Structure of (–)-penibruguieramine A (1) and its proposed biosynthetic pathway. 
 
 2 
A biosynthetic pathway has been proposed,
1
 as shown in Scheme 1, in which the 
bicyclic ring system is generated by an intramolecular aldol-type reaction of 
proline-pentaketide amide 2.
2
 In this process, the chiral center of the proline moiety 
in 2 might be destroyed by trigonalization and regenerated along with the adjacent 
stereocenters. Enzymes are most likely involved in this biosynthesis because most 
chiral natural products are synthesized in nature via enzyme-mediated catalysis. 
We envisioned that the asymmetric synthesis of penibruguieramine A (1) could 
be achieved from the ester derivatives of 2 without the aid of external chiral 
influences if the principles of ‘memory of chirality’ (MOC) and ‘dynamic kinetic 
resolution’ (DKR) were applied to the aldol reaction step.
3–5 
MOC and DKR are 
attractive strategies for asymmetric synthesis. Although there have been reports on 
the use of DKR, only few studies on the application of MOC to the total synthesis 
of natural products have been reported.
6,7
 In addition, the combination of these two 
concepts has not been previously reported for asymmetric synthesis.
8
 In this 
communication, we report the use of MOC and DKR for the first total synthesis of 
(–)-penibruguieramine A (1) from L-proline. Our synthesis follows the biosynthetic 
pathway proposed for 1 and features the asymmetric construction of stereocenters 





II. Results and Discussion 
 
As outlined in Scheme 2, we envisioned that the intramolecular aldol reaction of 
proline ester 3 would afford bicyclic compound 4 with the correct absolute and 
relative configuration required to proceed to penibruguieramine A (1). The chiral 
center of the proline moiety could direct the stereochemical course of the aldol 
reaction and could be preserved in the reaction product. For the success of this 
MOC reaction, axially chiral enolate 5 (with an arbitrary enolate geometry) should 
be formed selectively over ent-5 via favored conformer 3-I. In addition, chiral 
enolate 5 must have a sufficiently large energy barrier against racemization.
3
 We 
anticipated the successful outcome of this reaction after considering the study 
reported by Stoodley et al. demonstrating the use of MOC in an aldol reaction of 
simpler proline derivatives.
10
 In that report, although the diastereoselectivity and 
yield were low, a certain degree of configuration retention was obtained at the 
chiral center of the proline moiety. 
The stereochemistry at the C-2 position of aldol product 4 can be introduced prior 
to the aldol reaction step. However, the C-2 stereocenter of 3 would not be retained 
over the course of the reaction due to facile enolization. We envisioned that if the 
DKR process occurred at the C-2 position during the aldol reaction and the reaction 
proceeded via conformationally favored intermediate 5, then the C-2 stereocenter 
 
 4 
would not require installation.
 
Based on this assumption, the aldol substrate 
employed in this total synthesis was prepared as a diastereomeric mixture at the C-
2 position. 
 
Scheme 2. Synthetic strategies for the total synthesis of (–)-penibruguieramine A (1). 
Our total synthesis started from known bromide 6,
11
 which was readily prepared 
from commercial alcohol 7 (Scheme 3). The alkylation of the dianion of ethyl 2-




which was coupled with L-proline tert-butyl ester (11) to yield aldol substrate 3 as 
 
 5 
a diastereomeric mixture at the C-2 position in an overall good yield. The 
diastereomeric ratio of 3 was 1.4:1 implying that epimerization at C-2 occurred 
during the coupling reaction process (vide infra). 
 
Scheme 3. Synthesis of proline-pentaketide amide 3. DCC=N,N'-dicyclohexylcarbodiimide, 
DMAP=4-(N,N-dimethylamino)pyridine, THF= tetrahydrofuran. 
With substrate 3 in hand, we investigated the envisioned intramolecular aldol 
reaction.
 
In addition to the desired aldol reaction (path a, Table 1), 3 can undergo 
other competitive side reactions, including the Dieckmann condensation (path b) 
and the retro-Claisen reaction (path c). The bulky tert-butyl ester group of 3 was 
expected to be appropriate to avoid the side reaction via path b.
13
 Various bases and 
 
 6 
conditions were screened to obtain the desired product. The typical results are 
listed in Table 1.  




Entry Base (equiv) Solvent Time (h) Yield of 4
b
 (%) 
1 NaOEt (5) EtOH 9 77
c
 
2 LiOEt (5) EtOH 9 72 
3 KOEt (5) EtOH 6 66 
4 NaOMe (5) MeOH 24 30 
5 NaOiPr (5) iPrOH 3 49 
6 NaOtBu (5) tBuOH 16 0
d
 
7 TBAOH·30H2O (5) THF 12 61 
a Reactions were run with 3 (105 mg, 0.3 mmol) at a substrate concentration of 0.1 M. b 
Isolated yield. c 12 was also obtained in 10% yield. d Complex mixture. TBAOH=tetra-n-
butylammonium hydroxide. 
When substrate 3 was treated with NaOEt in EtOH, the reaction proceeded with 
satisfactory results to afford the desired aldol product 4 as a single diastereomer in 
77% yield after 9 h (entry 1). The only notable side product present in the reaction 
 
 7 
mixture was the aldol dehydration product 12. Other alkali metal ethoxides, such as 
LiOE and KOEt, also yielded the desired 4 without significant loss of yield (entries 
2 and 3). However, when 3 was treated with NaOMe (entry 4), the reaction 
suffered from low yield due to the retro-Claisen cleavage to provide 13a (21%) via 
path c and transesterification (8%). Other sodium alkoxides having bulky organic 
substituents, such as NaOiPr and NaOtBu, were also inappropriate for the aldol 
reaction and suffered from low yield and decomposition (entries 5 and 6). 
Sterically hindered organic bases, including 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU), failed to yield the desired product in an aprotic solvent (see the 
Experimental for details). Alkali metal hydroxides produced only a negligible 
amount of product, with most of the starting material remaining along with a small 
amount of 13b formed via hydrolytic retro-Claisen cleavage (path c). On the other 
hand, the quaternary ammonium hydroxide base in THF gave the product 4 in 
moderate yield (entry 7). These results indicated that the nature of the base, with 
bulkiness in particular, was important in determining the outcome of the reaction. 
Regardless of the nature of the base, the intramolecular aldol reaction of 3 
resulted in a single diastereomer (4). The other possible isomers were not detected 
in the crude mixture. The relative stereochemistry of 4, which was determined by 
2D NMR analysis, was identical to that of penibruguieramine A. The absolute and 





With this excellent stereochemical outcome in hand, the total 
synthesis of 1 was completed by reducing the sterically hindered tert-butyl ester 
group in 4 to the corresponding alcohol via two steps.
15
 The NMR and mass 
spectral data of the resulting 1 were identical to those of the natural product. The 
synthetic sample exhibited a negative optical rotation [[α]
22
D –21.3 (c 0.05, 
CHCl3)], which is consistent with that of the natural compound [[α]
22
D –22 (c 0.05, 
CHCl3)].
1
 This result indicates that the absolute configuration proposed for the 
natural compound was correct. 
 
Scheme 4. Crystal structure of 4
14
 and completion of the synthesis of (–)-
penibruguieramine A (1). BOP=benzotriazolyloxy-tris(dimethylamino) phosphonium 
hexafluorophosphate, DIPEA=N,N-diisopropylethylamine, TFA=trifluoroacetic acid. 
The enantiomeric purity of 1 was greater than 99% (see the Experimental for 
details). These results confirmed that MOC was exerted during the intramolecular 
aldol reaction of 3. The virtually complete retention of chirality obtained in the 
 
 9 
polar protic solvent is remarkable considering the prior observations in which the 
competitive protonation of the enolate decreased the enantioselectivities of the 
MOC reactions in protic solvents.
16 
 
Scheme 5. Exploratory studies to determine the mechanism of the aldol reaction. 
To understand our excellent stereochemical outcome, we performed additional 
experiments with model substrate 3′ (Scheme 5a), which consists of a UV-
absorbing chromophore that allows for facile reaction analysis. When we analyzed 
the remaining aldol substrate in the incomplete reaction mixture, it was found that 





addition, the hydrogen at the proline stereocenter was gradually replaced with 
deuterium when the aldol reaction was conducted in EtOD (Scheme 5a; see the 
Experimental for details). These observations suggested that the unreacted ester 
enolate intermediate was protonated with complete retention of configuration to 
regenerate the aldol substrate, which may result in excellent MOC in a protic 
solvent environment.
 
A major factor for this MOC during 
deprotonation/protonation may be the torsional strain that develops when the 
axially chiral enolate, such as 5, is protonated from the si-face, leading to the C-8 
epimer of 3. 
When the two separated C-2 diastereomers of 3 were independently subjected to 
the optimized aldol reaction conditions, each reaction yielded the same results and 
afforded 4 in good yield. The monitoring of each reaction by NMR indicated the 
rapid epimerization at the C-2 position and the gradual formation of aldol product 4 
as the only diastereomer (Scheme 5b; see the Experimental for details). The 
diastereomeric ratios of the two isomers from the two reactions were 1.4:1 after 10 
min, and the ratio remained constant. The ratio was the same prior to the separation, 
and may reflect the thermodynamic stability of the isomers.
 
Based on these 
observations, we are confident that DKR occurred during the reaction. 
Because 4 was the only aldol product that appeared from the beginning of the 
reaction and because other diastereomers were not detected during the reaction, 4 
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can be regarded as the kinetic product. Our computational study indicated that the 
obtained aldol product 4 is the most stable among all of the possible diastereomers 
(see the Experimental for details). Therefore, the aldol product 4 is not only the 
kinetic product but also the thermodynamically favored product. 
 
Scheme 6. Proposed mechanism for the aldol reaction. 
Based on these results and earlier reports, an aldol reaction mechanism of 3 was 
proposed, as shown in Scheme 6. The presence of an acidic proton at the C-2 
stereocenter of substrate 3 allows for easy epimerization under basic conditions. 
The conformer 3-I is energetically more favored than 3-II due to minimized 1,3-
allylic strain,
10,17
 and the deprotonation reaction at the proline α position on 
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conformer 3-I generates an axially chiral enolate 5. This transient enolate can be 
converted back to 3 by protonation with complete configuration retention at the C-
8 position. Upon formation of 5, the C2-(S) isomer undergoes an intramolecular 
aldol reaction via conformer 5-I to yield aldol product 4. The reaction via 
conformer 5-II would be less favorable due to steric repulsion between the alkyl 
chain and the proline moiety. The aldol reaction of the C2-(R) isomer via 
conformer 5-III would not be favored because the methyl group hinders enolate 
addition to the carbonyl group. However, based on the DKR principle, this 
unfavorable C-2 epimer could participate in the reaction via epimerization.
18
 The 
excellent stereochemical outcome of the reaction may result from these kinetic 






In summary, using a biomimetic approach, the first total synthesis of (–)-
penibruguieramine A (1) was achieved. The principles of ‘memory of chirality’ and 
‘dynamic kinetic resolution’ were employed for the asymmetric synthesis using 
proline as the only chiral source. All three stereocenters were established in an 
intramolecular aldol reaction of proline-pentaketide amide 3 with complete 
diastereo- and enantioselectivity without the aid of an external chiral influence. The 
excellent MOC in the protic solvent environment may be associated with the return 
of the unreacted chiral enolate intermediate to the starting material by protonation 
with complete retention of configuration. The excellent diastereoselectivity is most 
likely related to the kinetic and thermodynamic preferences for the desired aldol 
product. Our synthesis is the first reported example of the combined use of MOC 





IV-1. General.  
 
All of the chemicals were of reagent grade and were used as received. All of the 
reactions were performed under an inert atmosphere consisting of dry nitrogen 
using distilled dry solvents. The reactions were monitored by thin layer 
chromatography (TLC) analysis using silica gel 60 F-254 TLC plates. Flash 
column chromatography was performed on silica gel (230-400 mesh). The melting 
points were measured using a Buchi B-540 melting point apparatus without 
correction. The optical rotations were measured using sodium light (D line 589.3 
nm) at 22 °C. 
1
H NMR (400 or 500 MHz) and 
13
C NMR (100 or 125 MHz) spectra 
were recorded in  units relative to the non-deuterated solvent as the internal 
reference. The IR spectra were recorded on a Fourier Transform Infrared 
spectrometer. High-resolution mass spectra (HRMS) were recorded using fast atom 
bombardment (FAB). HPLC was performed on an Agilent 1200 series instrument 
with a diode array detector (DAD) and CHIRALCEL OD-H column (0.46 × 25 cm, 




IV-2. Experimental procedure and spectroscopic data analysis 
 
IV-2-1. Synthesis of (–)-penibruguieramine A (1) 
Ethyl (E)-2-methyl-3-oxodec-8-enoate (9) 
 
To a suspension of NaH (60% oil dispersion, 7.20 g, 180 mmol) in THF (400 mL) 
was slowly added ethyl 2-methylacetoacetate (8, 17.0 mL, 120 mmol) at 0 °C. 
After 30 min, nBuLi (2.5 M in hexane, 52.8 mL, 132 mmol) was added slowly at 
0 °C. The mixture was stirred for an additional 30 min prior to dropwise addition of 
(E)-6-bromohex-2-ene (6, 6.52 g, 40.0 mmol). After 3 h of stirring at room 
temperature, the reaction was quenched by the slow addition of a saturated NH4Cl 
aqueous solution at 0 °C. Then, the mixture was extracted twice with ether. The 
combined organic layers were washed with brine, dried over MgSO4, and 
concentrated in vacuo. The residue was purified by flash chromatography on silica 
gel (hexane/EtOAc, 15:1) to yield 9 (6.88 g, 76%) as a light yellow liquid: 
1
H 
NMR (400 MHz, CDCl3) δ 5.34–5.25 (m, 2H), 4.08 (q, J = 7.1 Hz, 2H), 3.41 (q, J 
= 7.1 Hz, 1H), 2.52–2.35 (m, 2H), 1.90–1.85 (m, 2H), 1.53 (d, J = 4.2 Hz, 3H), 
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1.51–1.45 (m, 2H), 1.27–1.23 (m, 2H), 1.22 (d, J = 7.2 Hz, 3H), 1.17 (t, J = 7.1 Hz, 
3H); 
13
C NMR (100 MHz, CDCl3) δ 205.6, 170.4, 130.7, 124.9, 61.0, 52.6, 40.1, 
32.1, 28.7, 22.8, 17.6, 13.9, 12.5; IR (neat, cm
-1
) υmax 2985, 2938, 2860, 1741, 1714, 
1453, 1375, 1238, 1189, 966, 859; HRMS (FAB): calcd. for C13H23O3 [M+H]
+
 
227.1647, found 227.1656. 
 
(E)-2-Methyl-3-oxodec-8-enoic acid (10) 
 
To a solution of 9 (4.52 g, 20.0 mmol) in MeOH (100 mL) was added 10% KOH 
aqueous solution (100 mL) at 0 °C, and the resulting mixture was stirred at room 
temperature for 1 h. The reaction mixture was acidified with a 10% HCl aqueous 
solution and then extracted twice with EtOAc. The combined organic layers were 
dried over MgSO4 and concentrated in vacuo to afford 10 (3.85 g, 97%) as a 
colorless oil, which was used in the subsequent step without further purification: 
1
H NMR (400 MHz, CDCl3) δ 11.6 (brs, 1H), 5.38–5.28 (m, 2H), 3.52 (q, J = 7.1 
Hz, 1H), 2.62–2.44 (m, 2H), 1.93–1.89 (m, 2H), 1.56 (d, J = 4.7 Hz, 3H), 1.53–
1.49 (m, 2H), 1.32–1.24 (m, 2H), 1.29 (d, J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ 205.7, 176.2, 130.7, 125.0, 52.3, 41.3, 32.1, 28.7, 22.8, 17.6, 12.5; IR 
(neat, cm
-1
) υmax 3022, 2935, 2858, 1707, 1455, 1411, 1235, 966; HRMS (FAB): 
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calcd. for C11H19O3 [M+H]
+
 199.1334, found 199.1333.  
 
tert-Butyl ((E)-2-methyl-3-oxodec-8-enoyl)-L-prolinate (3) 
 
To a solution of 10 (2.50 g, 12.6 mmol) and L-proline tert-butyl ester (11, 2.56 g, 
12.6 mmol) in CH2Cl2 (100 mL) was added DCC (2.87 g, 13.9 mmol) and DMAP 
(122 mg, 1.0 mmol) at 0 °C. The reaction mixture was stirred at room temperature 
for 5 h and then filtered through a Celite pad. The filtrate was washed with a 
saturated NH4Cl aqueous solution, dried over MgSO4 and concentrated in vacuo. 
The residue was purified by flash chromatography on silica gel (hexane/EtOAc, 
3:1) to yield a 1.4:1 mixture of 3A and 3B (3.50 g, 79%) as a colorless oil. Small 
amounts of 3A and 3B were carefully isolated from the mixture via 
chromatography on silica gel (hexane/EtOAc, 4:1) for spectroscopic analysis.  
3A (major isomer): []
22
D –24.3 (c 0.5, CHCl3); 
1
H NMR (400 MHz, C5D5N, two 
rotamers in a 5:1 ratio) δ 5.40–5.34 (m, 2H), 4.82 (dd, J = 8.1 Hz, 2.8 Hz, 1/6H), 
4.56 (dd, J = 8.5 Hz, 4.1 Hz, 5/6H), 3.78 (q, J = 6.9 Hz, 1H), 3.74–3.69 (m, 1H), 
3.67–3.60 (m, 1/6H), 3.55–3.49 (m, 5/6H), 2.86 (td, J = 17.7 Hz, 7.4 Hz, 1H), 2.67 
(td, J = 17.7 Hz, 7.1 Hz, 1H), 2.11–2.02 (m, 1H), 1.99–1.94 (m, 2H), 1.93–1.86 (m, 
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2H), 1.81–1.73 (m, 1H), 1.72–1.65 (m, 2H), 1.56–1.52 (m, 3H), 1.47 and 1.43 
(each s, total 9H in a 5:1 ratio), 1.42 (d, J = 7.0 Hz, 3H), 1.38–1.27 (m, 2H); 
13
C 
NMR (100 MHz, C5D5N; rotamer 1/ rotamer 2) δ 206.6/206.3, 172.0/171.7, 
169.8/169.5, 131.6/131.5, 125.1/125.0, 82.1/81.0, 60.8/60.2, 53.0/52.6, 47.8/47.1, 
40.1/40.0, 32.6/31.6, 29.4, 29.3/29.1, 27.9/27.8, 25.0, 23.4/22.8, 18.0, 13.7/13.1; IR 
(neat, cm
-1
) υmax 2979, 2935, 2882, 1729, 1643, 1417, 1367, 1151, 966; HRMS 
(FAB): calcd. for C20H34NO4 [M+H]
+
 352.2488, found 352.2486. 
3B (minor isomer): []
22
D –88.6 (c 0.5, CHCl3); 
1
H NMR (400 MHz, C5D5N, two 
rotamers in a 4:1 ratio) δ 5.30–5.23 (m, 2H), 4.58 (dd, J = 8.1 Hz, 2.5 Hz, 1/5H), 
4.54 (dd, J = 8.5 Hz, 3.7 Hz, 4/5H), 3.75 (q, J = 7.0 Hz, 4/5H), 3.69–3.66 (m, 
1/5H), 3.60–3.51 (m, 2H), 2.81 (td, J = 17.4 Hz, 7.5 Hz, 1/5H), 2.65–2.56 (m, 1H), 
2.48 (td, J = 17.4 Hz, 7.2 Hz, 4/5H), 2.08–1.96 (m, 1H), 1.91–1.80 (m, 4H), 1.77–
1.71 (m, 1H), 1.65–1.51 (m, 2H), 1.49–1.48 (m, 3H), 1.42 and 1.37 (each s, total 
9H in a 1:4 ratio), 1.39 (d, J = 7.0 Hz, 3H), 1.28–1.19 (m, 2H); 
13
C NMR (100 
MHz, C5D5N; rotamer 1/ rotamer 2) δ 206.5/206.0, 172.0/171.6, 170.5/169.8, 
131.54/131.48, 125.1/125.0, 82.2/80.8, 60.7/60.3, 52.6/52.4, 47.6/46.9, 40.6/40.5, 
32.7/32.6, 31.6/29.5, 29.3/29.2, 27.93/27.85, 25.0/23.6, 23.5/22.6, 18.0, 13.8/13.0; 
IR (neat, cm
-1
) υmax 2979, 2935, 2882, 1726, 1643, 1417, 1368, 1151, 966; HRMS 
(FAB): calcd. for C20H34NO4 [M+H]
+




Representative procedure for the intramolecular aldol reaction of 3 and 
characterization of compounds.  
 
To a solution of 3 (105 mg, 0.3 mmol) in EtOH (3 mL) was added NaOEt (102 
mg, 1.5 mmol), and the mixture was stirred for 9 h at room temperature. The 
reaction was quenched by the addition of a saturated NH4Cl aqueous solution and 
extracted twice with EtOAc. The combined organic layers were dried over MgSO4 
and concentrated in vacuo. The residue was purified by flash chromatography on 
silica gel (hexane/EtOAc, 2:1) to afford 4 (81.6 mg, 77%) as a white crystalline 
solid and 12 (10.0 mg, 10%) as a colorless oil.  
tert-Butyl (1R,2S,7aR)-1-((E)-hept-5-en-1-yl)-1-hydroxy-2-methyl-3-
oxotetrahydro-1H-pyrrolizine-7a(5H)-carboxylate (4) : white crystalline solid; 
m.p. 104–105 °C; []
22
D –64.0 (c 0.5, CHCl3); 
1
H NMR (400 MHz, CDCl3) δ 5.34–
5.32 (m, 2H), 3.44 (td, J = 11.0 Hz, 7.6 Hz, 1H), 2.93 (ddd, J = 11.2 Hz, 8.0 Hz, 
3.9 Hz, 1H), 2.83 (q, J = 7.2 Hz, 1H), 2.51 (brs, 1H), 2.18–2.08 (m, 2H), 1.97–1.86 
(m, 3H), 1.84–1.79 (m, 1H), 1.59–1.52 (m, 5H), 1.46–1.37 (m, 2H), 1.40 (s, 9H), 
1.30–1.22 (m, 2H), 1.00 (d, J = 7.3 Hz, 3H); 
1
H NMR (400 MHz, C5D5N) δ 6.71 (s, 
1H), 5.51–5.40 (m, 2H), 3.60 (td, J = 10.9 Hz, 7.5 Hz, 1H), 3.24 (q, J = 7.2 Hz, 
1H), 3.06 (ddd, J = 11.3 Hz, 7.6 Hz, 4.4 Hz, 1H), 2.59 (td, J = 12.6 Hz, 8.8 Hz, 1H), 
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2.41 (ddd, J = 12.4 Hz, 7.4 Hz, 4.7 Hz, 1H), 2.09–2.04 (m, 2H), 1.96–1.78 (m, 5H), 
1.75–1.68 (m, 1H), 1.59 (d, J = 4.9 Hz, 3H), 1.50 (s, 9H), 1.47–1.34 (m, 2H), 1.44 
(d, J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 175.0, 171.5, 131.0, 124.8, 
82.1, 81.3, 80.4, 49.3, 40.9, 35.6, 32.4, 30.1, 27.73, 27.69, 26.0, 22.8, 17.7, 7.2; IR 
(neat, cm
-1
) υmax 3315, 2980, 2920, 2883, 1718, 1676, 1442, 1367, 1223, 1153, 
1104, 965, 847, 760; HRMS (FAB): calcd. for C20H34NO4 [M+H]
+
 352.2488, found 
352.2481. 
tert-Butyl (R,E)-7-(hept-5-en-1-yl)-6-methyl-5-oxo-2,3-dihydro-1H-
pyrrolizine-7a(5H)-carboxylate (12) : colorless oil; []
22
D 85.9 (c 0.5, CHCl3); 
1
H NMR (400 MHz, CDCl3) δ 5.39–5.28 (m, 2H), 3.46 (td, J = 11.0 Hz, 8.7 Hz, 
1H), 3.19 (ddd, J = 11.3 Hz, 8.9 Hz, 2.6 Hz, 1H), 2.46 (dd, J = 12.1 Hz, 6.5 Hz, 
1H), 2.40–2.32 (m, 1H), 2.25–2.06 (m, 3H), 1.93–1.89 (m, 2H), 1.71 (s, 3H), 1.57 
(d, J = 4.8 Hz, 3H), 1.54–1.47 (m, 1H), 1.38 (s, 9H), 1.35–1.20 (m, 4H); 
13
C NMR 
(100 MHz, CDCl3) δ 176.1, 169.5, 154.6, 130.7, 130.1, 125.1, 82.2, 79.2, 41.4, 
33.1, 32.1, 29.5, 28.4, 27.7, 27.1, 26.9, 17.7, 9.0; IR (neat, cm
-1
) υmax 2976, 2933, 
2860, 1726, 1695, 1367, 1293, 1152, 1106, 966, 843, 763; HRMS (FAB): calcd. for 
C20H32NO3 [M+H]
+




Table S1. Additional conditions tested to optimize the intramolecular aldol reaction of 3 




Entry Base (equiv) Solvent Time (h) Yield
b
 (%) 
1 KOtBu (5) tBuOH 3 0
c 
2 KOtBu (5) THF 3 0
c 
3 DBU (5) THF 16 0
d
 
4 DTBPy (5) THF 16 0
d
 
5 KOH (5) H2O/THF (3/1) 72 <2
e
 
6 CsOH (5) H2O/THF (3/1) 72 <2
e
 
a Reactions were run with 3 (105 mg, 0.3 mmol) at a substrate concentration of 0.1 M. b 
Determined by 1H NMR analysis. c Complex mixture. d 3 was recovered. e 3 was recovered 
in ca. 80% yield. DBU =1,8-diazabicyclo[5.4.0]undec-7-ene. DTBPy=2,6-di-tert-
butylpyridine.  
 
(–)-Penibrugueiramine A (1)  
 
To a solution of 4 (52.7 mg, 0.15 mmol) in CH2Cl2 (1.0 mL) was added 
trifluoroacetic acid (TFA) (0.5 mL) at 0 °C, and the mixture was stirred for 16 h at 
room temperature. The reaction mixture was concentrated in vacuo to afford crude 
S1 as a white solid, which was used in the subsequent step without further 
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purification: m.p. 206 °C (dec.); []
22
D –70.7 (c 0.5, MeOH); 
1
H NMR (400 MHz, 
CD3OD) δ 5.46–5.35 (m, 2H), 3.44 (td, J = 10.9 Hz, 7.8 Hz, 1H), 3.02 (ddd, J = 
11.2 Hz, 8.4 Hz, 3.4 Hz, 1H), 2.94 (q, J = 7.2 Hz, 1H), 2.26–2.22 (m, 2H), 2.09–
2.02 (m, 1H), 1.99–1.90 (m, 3H), 1.73–1.66 (m, 1H), 1.62 (d, J = 3.2 Hz, 3H), 
1.57–1.45 (m, 3H), 1.34–1.29 (m, 2H), 1.04 (d, J = 7.2 Hz, 3H); 
13
C NMR (100 
MHz, CD3OD) δ 178.6, 176.4, 133.2, 126.4, 83.3, 82.7, 51.7, 42.8, 37.6, 34.2, 32.1, 
29.3, 27.7, 24.9, 18.9, 8.6; IR (neat, cm
-1
) υmax 3415, 2943, 2894, 2853, 2479, 1693, 
1633, 1451, 1257, 1222, 1096, 983, 959, 710; HRMS (FAB): calcd. for C16H26NO4 
[M+H]
+
 296.1862, found 296.1863.  
To a solution of crude S1 in THF (2.0 mL) was added benzotriazol-1-
yloxytris(dimethylamino)phosphonium hexafluorophosphate (BOP, 75.0 mg, 0.17 
mmol) and diisopropylethyl amine (32.0 μL, 0.23 mmol) at room temperature. The 
resulting solution was stirred for 10 min, and then NaBH4 (17.0 mg, 0.45 mmol) 
was added in portions at 0 °C. After 1 h of stirring at room temperature, the 
reaction was quenched by the addition of a saturated NH4Cl aqueous solution and 
was extracted four times with EtOAc. The combined organic layers were dried over 
MgSO4 and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (CH2Cl2/MeOH, 20:1) to yield 1 (36.1 mg, 86%) as a 
white solid: m.p. 173–174 °C; []
22
D –21.3 (c 0.05, CHCl3); 
1
H NMR (500 MHz, 
CDCl3) δ 5.44–5.35 (m, 2H), 3.77 (ddd, J = 11.5 Hz, 8.1 Hz, 3.6 Hz, 1H), 3.69 (d, J 
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= 11.8 Hz, 1H), 3.52 (d, J = 11.9 Hz, 1H), 2.96 (q, J = 7.1 Hz, 1H), 2.93–2.90 (m, 
1H), 2.25 (ddd, J = 13.2 Hz, 9.0 Hz, 4.5 Hz, 1H) 2.15 (brs, 1H, OH), 2.02–1.96 (m, 
2H), 1.95–1.90 (m, 1H), 1.88–1.81 (m, 1H), 1.71 (ddd, J = 14.3 Hz, 12.4 Hz, 4.1 
Hz, 1H), 1.63 (d, J = 4.9 Hz, 3H), 1.59 (dd, J = 14.5 Hz, 4.5 Hz, 1H), 1.56–1.50 (m, 
1H), 1.45 (td, J = 13.0 Hz, 8.0 Hz, 1H), 1.41 (s, 1H, OH), 1.39–1.33 (m, 2H), 1.28–
1.21 (m, 1H), 1.05 (d, J = 7.3 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 177.2, 131.0, 
125.2, 81.5, 75.8, 65.8, 49.1, 42.7, 34.2, 32.3, 30.0, 27.2, 26.5, 23.2, 17.9, 7.1; IR 
(neat, cm
-1
) υmax 3366, 3201, 2932, 2868, 1677, 1452, 1055, 969, 721; HRMS 
(FAB): calcd. for C16H28NO3 [M+H]
+
 282.2069, found 282.2078. 
 
Data comparison between natural and synthetic (–)-penibrugueiramine A. 
 
1H NMR  
(500 MHz, CDCl3) 
13C NMR  
(125 MHz, CDCl3) 
Natural1 Synthetic Natural
1 Synthetic 
5.41 (m, 2H) 5.44–5.35 (m, 2H) 177.4 177.2 
3.78 (m, 1H) 
3.77 (ddd, J = 11.5 Hz,  
8.1 Hz, 3.6 Hz, 1H) 
130.9 131.0 
3.71 (d, J = 11.9 Hz, 1H) 3.69 (d, J = 11.8 Hz, 1H) 125.2 125.2 
3.54 (d, J = 11.9 Hz, 1H) 3.52 (d, J = 11.9 Hz, 1H) 81.6 81.5 
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2.98 (q, J = 7.2 Hz, 1H) 2.96 (q, J = 7.1 Hz, 1H) 75.8 75.8 
2.94 (m, 1H) 2.93–2.90 (m, 1H) 65.8 65.8 
2.228 (ddd, J = 13.5 Hz, 11.0 
Hz, 6.3 Hz, 1H) 
2.25 (ddd, J = 13.2 Hz,  
9.0 Hz, 4.5 Hz, 1H) 
49.1 49.1 
 2.15 (brs, 1H, OH) 42.8 42.7 
2.00 (m, 2H) 2.02–1.96 (m, 2H) 34.2 34.2 
1.95 (m, 1H) 1.95–1.90 (m, 1H) 32.3 32.3 
1.86 (ddd, J = 12.2 Hz,  
12.9 Hz, 6.3 Hz, 1H) 
1.88–1.81 (m, 1H) 30.0 30.0 
1.72 (m, 1H) 
1.71 (ddd, J = 14.3 Hz,  
12.4 Hz, 4.1 Hz, 1H) 
27.2 27.2 
1.65 (d, J = 4.9 Hz, 3H) 1.63 (d, J = 4.9 Hz, 3H) 26.5 26.5 
1.61 (dd, J = 14.5 Hz,  
4.5 Hz, 1H) 
1.59 (dd, J = 14.5 Hz,  
4.5 Hz, 1H) 
23.2 23.2 
1.54 (m, 1H) 1.56–1.50 (m, 1H) 17.9 17.9 
1.47 (m, 1H) 
1.45 (td, J = 13.0 Hz,  
8.0 Hz, 1H) 
7.1 7.1 
 1.41 (s, 1H, OH)   
1.38 (m, 1H) 1.39–1.33 (m, 2H)   
1.26 (m, 1H)    
1.24 (m, 1H) 1.28–1.21 (m, 1H)   
1.06 (d, J = 7.2 Hz, 3H) 1.05 (d, J = 7.3 Hz, 3H)   
 
Determination of the enantiomeric excess of 1 
a. Via the 
1
H NMR spectra of its Mosher ester derivatives 




To a solution of 1 (10.0 mg, 0.036 mmol) in CH2Cl2 (0.5 mL) was added 
trimethylamine (30.0 μL, 0.22 mmol) and a catalytic amount of DMAP at 0 °C. 
(R)-α-Methoxy-α-(trifluoromethyl)phenylacetyl chloride (16.1 μL, 0.086 mmol) 
was added, and the reaction mixture was stirred for 20 min at room temperature. 
The reaction was quenched by the addition of a saturated NH4Cl aqueous solution 
and extracted twice with CH2Cl2. The combined organic layers were dried over 
MgSO4 and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (hexane/EtOAc, 1:1) to yield (S)-S2 (17.3 mg, 97%) 
as a colorless oil: 
1
H NMR (400 MHz, CDCl3) δ 7.48–7.38 (m, 5H), 5.43–5.31 (m, 
2H), 4.25 (d, J = 11.7 Hz, 1H), 4.15 (d, J = 11.7 Hz, 1H), 3.70 (ddd, J = 11.6 Hz, 
8.0 Hz, 3.7 Hz, 1H), 3.49 (s, 3H), 2.77 (td, J = 11.3 Hz, 8.0 Hz, 1H), 2.54 (q, J = 
7.1 Hz, 1H), 2.31 (ddd, J = 13.4 Hz, 9.0 Hz, 4.7 Hz, 1H), 1.96–1.84 (m, 3H), 1.82–
1.77 (m, 1H), 1.64 (d, J = 5.1 Hz, 3H), 1.57 (brs, 1H), 1.46–1.29 (m, 3H), 1.27–
1.20 (m, 3H), 1.16–1.09 (m, 1H), 0.92 (d, J = 7. 2 Hz, 3H).  
(R)-S2 was prepared according to the procedure described above for (S)-S2 using 
(S)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride (16.1 μL, 0.086 mmol) 
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instead of (R)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride to yield (R)-S2 
(17.1 mg, 96%) as a colorless oil: 
1
H NMR (400 MHz, CDCl3) δ 7.47–7.39 (m, 
5H), 5.44–5.33 (m, 2H), 4.33 (d, J = 11.4 Hz, 1H), 4.19 (d, J = 11.4 Hz, 1H), 3.68 
(ddd, J = 11.5 Hz, 7.1 Hz, 4.4 Hz, 1H), 3.47 (s, 3H), 2.72 (td, J = 11.2 Hz, 8.1 Hz, 
1H), 2.56 (q, J = 7.1 Hz, 1H), 2.28 (ddd, J = 13.2 Hz, 8.0 Hz, 5.4 Hz, 1H), 1.97–
1.94 (m, 2H), 1.77–1.68 (m, 2H), 1.64 (d, J = 5.1 Hz, 3H), 1.50–1.44 (m, 2H), 
1.42–1.36 (m, 1H), 1.33–1.18 (m, 5H), 0.98 (d, J = 7. 2 Hz, 3H).  
Scheme S2. Preparation of the (S)-Mosher ester of rac-1. 
 
Rac-1 was prepared according to the procedure described above for 1 using rac-
11 instead of 11. Rac-1 (10 mg, 0.036 mmol) was subjected to Mosher ester 
formation with (R)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride (16.1 μL, 
0.086 mmol) according to the procedure described above for (S)-S2 to yield the 
(S)-Mosher ester of rac-1 (17.3 mg, 97%) as a colorless oil.  
The 
1
H NMR spectra of the crude products of (S)-S2 and (R)-S2 were obtained 
and compared with the 
1
H NMR spectrum of the (S)-Mosher ester of rac-1. Based 




Figure S1. Comparison of the 
1
H NMR spectra of crude (S)-S2, (R)-S2 and the (S)-Mosher 
ester of rac-1 (400 MHz, CDCl3).  
 
b. Via separation using chiral HPLC  
Scheme S3. Preparation of the S3. 
 
To a solution of 1 (5.00 mg, 0.018 mmol) in CH2Cl2 (0.5 mL) was added 
trimethylamine (10.0 μL, 0.072 mmol) and a catalytic amount of DMAP at 0 °C. 
Benzoyl chloride (4.18 μL, 0.036 mmol) was added, and the reaction mixture was 
stirred for 30 min at room temperature. The reaction mixture was concentrated in 
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vacuo The residue was purified by flash chromatography on silica gel 
(hexane/EtOAc, 1:2) to yield S3 (6.50 mg, 95%) as a colorless oil: 
1
H NMR (400 
MHz, CDCl3) δ 7.95 (d, J = 7.4 Hz, 2H), 7.57 (t, J = 7.5 Hz, 1H), 7.44 (t, J = 7.7 
Hz, 2H), 5.41–5.33 (m, 2H), 4.38 (d, J = 11.7 Hz, 1H), 4.32 (d, J = 11.7 Hz, 1H), 
3.79 (ddd, J = 11.6 Hz, 8.2 Hz, 3.7 Hz, 1H), 3.03 (td, J = 11.1 Hz, 8.2 Hz, 1H), 
2.92 (q, J = 7.2 Hz, 1H), 2.40 (ddd, J = 13.4 Hz, 9.1 Hz, 4.7 Hz, 1H), 2.07–2.02 (m, 
1H), 1.96–1.88 (m, 3H), 1.71–1.64 (m, 3H), 1.62–1.51 (m, 4H), 1.37–1.28 (m, 3H), 
1.10 (d, J = 7. 3 Hz, 3H).  
Scheme S4. Preparation of the rac-S3. 
 
Rac-1 (5.00 mg, 0.018 mmol) was subjected to benzoate formation with benzoyl 
chloride (4.18 μL, 0.036 mmol) according to the procedure described above for S3 
to yield rac-S3 (6.20 mg, 91%) as a colorless oil. 
The enantiomeric purity of S3 was analyzed by chiral HPLC. The chiral HPLC 
chromatogram of S3 was compared with that of rac-S3. Based on this comparison, 




Figure S2. Chiral HPLC chromatograms of S3 and rac-S3.  
HPLC conditions: CHIRALCEL OD-H (0.46 × 25 cm, 5 μm), hexane/2-propanol 
= 90:10, flow rate = 0.5 mL/min, λ = 225.4 nm. The retention times are shown in 
Figure S2.  
 
IV-2-2. Exploratory studies to determine the mechanism of the aldol 
reaction. 
To understand our ‘memory of chirality’ (MOC) results, we employed a model 
substrate 3′, which contained a UV-absorbing chromophore. 3′ was prepared 




Scheme S5. Preparation of 3′ 
 
To a suspension of NaH (60% oil dispersion, 480 mg, 12.0 mmol) in THF (40 
mL) was slowly added ethyl 2-methylacetoacetate (8, 1.13 mL, 8.0 mmol) at 0 °C. 
After 30 min, nBuLi (2.5 M in hexane, 3.5 mL, 8.8 mmol) was added slowly at 
0 °C. The mixture was stirred for an additional 30 min prior to dropwise addition of 
cinnamyl bromide (S4, 1.58 g, 8.0 mmol) in THF (10 mL). After 30 min of stirring 
at room temperature, the reaction was quenched by the slow addition of a saturated 
NH4Cl aqueous solution at 0 °C. Then, the mixture was extracted twice with ether. 
The combined organic layers were washed with brine, dried over MgSO4, and 
concentrated in vacuo. The residue was purified by flash chromatography on silica 
gel (hexane/EtOAc, 15:1) to afford S5 (1.27 g, 61%) as a light yellow liquid.  
To a solution of S5 (1.27 g, 4.9 mmol) in MeOH (50 mL) was added 10% KOH 
aqueous solution (50 mL) at 0 °C, and the resulting mixture was stirred at room 
temperature for 1 h. The reaction mixture was acidified with a 10% HCl aqueous 
solution and then extracted twice with EtOAc. The combined organic layers were 
dried over MgSO4 and concentrated in vacuo to yield the crude acid as a colorless 
oil, which was used in the subsequent step without further purification.  
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To a solution of this crude acid and L-proline tert-butyl ester (11, 840 mg, 4.9 
mmol) in CH2Cl2 (50 mL) was added DCC (1.01 g, 4.9 mmol) and DMAP (47.6 
mg, 0.39 mmol) at 0 °C. The reaction mixture was stirred at room temperature for 5 
h and then filtered through a Celite pad. The filtrate was washed with a saturated 
NH4Cl aqueous solution, dried over MgSO4 and concentrated in vacuo. The residue 
was purified by flash chromatography on silica gel (hexane/EtOAc, 3:1) to yield a 
1.3:1 diastereomeric mixture of 3′ (1.44 g, 76% in 2 steps) as a light yellow oil. A 
small amount of 3′A and 3′B was carefully isolated from the mixture by 
chromatography on silica gel (hexane/EtOAc, 4:1) for spectroscopic analysis.  
3′A (major isomer): []
22
D –15.4 (c 0.3, CHCl3); 
1
H NMR (400 MHz, C5D5N, 
two rotamers in a 4:1 ratio) δ 7.44–7.18 (m, 5H), 6.54–6.33 (m, 2H), 4.84 (dd, J = 
7.9 Hz, 2.8 Hz, 1/5H), 4.57 (dd, J = 8.5 Hz, 4.0 Hz, 4/5H), 3.81 (q, J = 6.8 Hz, 1H), 
3.73–3.67 (m, 1H), 3.64–3.59 (m, 1/5H), 3.50 (td, J = 9.7 Hz, 6.7 Hz, 4/5H), 3.06 
(td, J = 17.8 Hz, 7.3 Hz, 1H), 2.91–2.83 (m, 1H), 2.62–2.49 (m, 2H), 2.08–2.00 (m, 
1H), 1.94–1.84 (m, 2H), 1.77–1.69 (m, 1H), 1.44 and 1.42 (each s, total 9H in a 4:1 
ratio), 1.42 (d, J = 6.6 Hz, 3H); 
13
C NMR (100 MHz, C5D5N; rotamer 1/ rotamer 2) 
δ 205.9/205.5, 171.7, 169.7/169.4. 138.2/138.1, 131.0/130.9, 129.9/129.7, 128.9, 
127.4/127.3, 126.5, 82.1/81.1, 60.8/60.3, 53.1/52.7, 47.8/47.1, 40.3/39.8, 31.5/29.5, 
27.8/27.7, 27.3/27.2, 25.0/22.7, 13.1/13.0; IR (neat, cm
-1
) υmax 2979, 2934, 3880, 





 386.2331, found 386.2327. 
3′B (minor isomer): []
22
D –56.9 (c 0.5, CHCl3); 
1
H NMR (400 MHz, C5D5N, 
two rotamers in a 4:1 ratio) δ 7.40–7.16 (m, 5H), 6.46–6.24 (m, 2H), 4.67 (dd, J = 
7.8 Hz, 2.8 Hz, 1/5H), 4.61 (dd, J = 8.5 Hz, 3.6 Hz, 4/5H), 3.85 (q, J = 7.0 Hz, 
4/5H), 3.80–3.74 (m, 2/5H), 3.70 (q, J = 6.9 Hz, 1/5H), 3.65–3.57 (m, 8/5H), 3.16–
3.02 (m, 1/5H), 2.93–2.83 (m, 1H), 2.78–2.70 (m, 4/5H), 2.63–2.52 (m, 2H), 2.17–
1.99 (m, 1H), 1.94–1.85 (m, 2H), 1.80–1.67 (m, 1H), 1.47 (d, J = 7.7 Hz, 3H), 1.46 
and 1.43 (each s, total 9H in a 1:4 ratio); 
13
C NMR (100 MHz, C5D5N; rotamer 1/ 
rotamer 2) δ 205.9/205.4, 172.1/171.6, 170.5/169.7, 138.1, 131.0/130.8, 
130.0/129.8, 128.91/128.89, 127.4/127.3, 126.5, 82.3/80.8, 60.7/60.3, 52.7/52.6, 
47.7/46.9, 40.3/40.2, 31.6/29.5, 27.9/27.8, 27.5/27.4, 25.0/22.6, 13.9/13.0; IR (neat, 
cm
-1
) υmax 2980, 2932, 1722, 1639, 1420, 1367, 1150, 966, 735, 694; HRMS 
(FAB): calcd. for C23H32NO4 [M+H]
+
 386.2331, found 386.2325. 
 
IV-2-2-1. Chiral HPLC chromatograms of 3′ 
Using 3′, we analyzed the remaining aldol substrate of the incomplete reaction 
mixture (NaOEt/EtOH, RT, after 0.5, 1 and 2 h) by chiral HPLC. The 
chromatograms were compared with the chromatogram obtained from an analogue 
of 3′, which was prepared from rac-11. As shown in Figure S3, only two peaks 
were identified, which correspond to the two C-2 diastereomers of 3′, and no peaks 
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due to the racemization at the proline stereocenter were observed. The proline 
stereocenter was not racemized under the optimized aldol reaction conditions.  
HPLC conditions : CHIRALCEL OD-H (0.46 × 25 cm, 5 μm), hexane/2-propanol 
= 90:10, flow rate = 0.7 mL/min, λ = 254 nm. The retention times are shown in 









Figure S3. Chiral HPLC chromatograms of 3′ after the corresponding reaction times under 
the optimized aldol reaction conditions.  
4′: m.p. 159–160 °C; []
22
D –93.8 (c 0.5, CHCl3); 
1
H NMR (400 MHz, CDCl3) δ 
7.30–7.24 (m, 4H), 7.18–7.15 (m, 1H), 6.40 (d, J = 15.8 Hz, 1H), 6.21–6.14 (m, 
1H), 3.51 (td, J = 10.8 Hz, 7.7 Hz, 1H), 3.01 (ddd, J = 11.7 Hz, 7.8 Hz, 4.1 Hz, 1H), 
2.92 (q, J = 7.1 Hz, 1H), 2.67 (s, 1H), 2.44 (q, J = 7.4 Hz, 2H), 2.30–2.18 (m, 2H), 
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2.03–1.98 (m, 1H), 1.91–1.80 (m, 2H), 1.71–1.63 (m, 1H), 1.46 (s, 9H), 1.09 (d, J 
= 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 174.8, 171.5, 137.4, 130.2, 129.9, 
128.4, 126.9, 125.8, 82.4, 81.3, 80.4, 49.5, 41.0, 35.1, 27.9, 27.8, 26.9, 26.1, 7.2; 
IR (neat, cm
-1
) υmax 3283, 2976, 2954, 2881, 1717, 1678, 1443, 1152, 1103, 959, 
847, 757; HRMS (FAB): calcd. for C23H32NO4 [M+H]
+
 386.2331, found 386.2327. 
 
IV-2-2-2. Deuterium exchange experiment 
We conducted the intramolecular aldol reaction of 3′ in EtOD and analyzed the 
remaining 3′ ([D]-3′) in the incomplete reaction mixture (NaOEt/EtOD, RT, after 
0.5, 1 and 2 h) by 
1
H NMR. The hydrogen at the α-carbon of the proline moiety of 
3′ was gradually exchanged with deuterium over the course of the reaction. This 
result suggested that the aldol reaction of the transient enolate is not faster than the 
deuteration; otherwise, the deuterium would not be incorporated into the substrate.  
Note: Deuteration at the other two α-positions of the ketone of 3′ also occurred, 
which was more rapid than the deuteration at the α-carbon of proline. After 0.5 h, 
deuterium incorporation was observed at the C-2 and C-1′ positions at 
approximately 70% and 90%, respectively. The partial deuterium/hydrogen 
exchange during the work-up appears to be responsible for the incomplete 
deuteration at these positions. Significant levels of deuteration (>95% D) were also 
observed at the C-2 and C-1′ positions of [D]-4′.  
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Entry Time (h) 








1 0.5 27 79 15 
2 1 79 49 44 
3 2 89 34 55 
a Reactions were run with 3′ (77 mg, 0.2 mmol) and NaOEt (68 mg, 1.0 






H NMR spectra of 3′ and [D]-3′ after the corresponding reaction times in 
EtOD (500 MHz, C5D5N).  
Overall, the chiral HPLC analysis and deuterium exchange experiment suggested 
that the unreacted enolate intermediate was protonated with complete retention of 
configuration to regenerate aldol substrate 3. This result may explain the excellent 
MOC in the protic solvent environment. 
 
IV-2-2-3. DKR of the C-2 diastereomers of 3. 
To verify that the reaction proceeded via DKR, the C-2 diastereomers of 3 were 
separated by careful column chromatography from the 1.4:1 mixture. The major 
isomer was assigned as 3A, and the minor isomer was assigned as 3B. The 
monitoring of each reaction by NMR indicated the rapid epimerization at the C-2 
position and the gradual formation of aldol product 4 as the only diastereomer. The 
diastereomeric ratio of the two isomers was 1.4:1 after 10 min, which remained 
constant. This ratio was the same prior to the separation, which may reflect the 
thermodynamic stability of the isomers. The rationale for these observations could 
be that one of the C-2 epimers of substrate 3 may be kinetically preferred in the 
intramolecular aldol reaction, and the other isomer undergoes facile epimerization 






H NMR spectra of the crude reaction mixture after the corresponding reaction 





IV-3. X-ray Crystallographic data for 4. 
 
Figure S6. X-ray crystallographic structure of 4.  
CCDC 1062803 (4) contains the supplementary crystallographic data for this 
paper. These data can be obtained free of charge from the Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.  
Table S3. Crystal data and structure refinement for 4. 
Identification code  4 
Empirical formula  C20H33NO4 
Formula weight  351.47 
Temperature  223(2) K 
Wavelength  1.54178 Å  
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 6.1810(6) Å  α = 90°. 
 b = 16.5751(15) Å  β = 90°. 







Density (calculated) 1.176 Mg/m
3
 




Crystal size 0.24 × 0.19 × 0.12 mm
3
 
Theta range for data collection 3.51 to 72.21°. 
Index ranges -7<=h<=7, -20<=k<=20, -23<=l<=23 
Reflections collected 36253 
Independent reflections 3759 [R(int) = 0.0388] 
Completeness to theta = 72.21° 96.50% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9264 and 0.8602 
Refinement method Full-matrix least-squares on F
2
 




Final R indices [I>2sigma(I)] R1 = 0.0487, wR2 = 0.1373 
R indices (all data) R1 = 0.0513, wR2 = 0.1426 
Absolute structure parameter 0.1(3) 




IV-3. Computational study 
General procedure for molecular energy calculations 
Computational energy minimization was performed on 4 and its diastereomers 
using the DMol3 program
 
in Material Studio 8.0
 
(Accelrys software, Inc., San 
Diego, CA). A generalized gradient approximation (GGA) for the Perdew, Burke 
and Ernzerhof (PBE) exchange-correlation function was applied with double-
numerical plus d-functions polarization (DNP), as implemented in DMol3. 
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Geometry optimization and energy minimization of the compounds 
The compounds were calculated to compare their energy levels using the method 
described above. This computational energy minimization demonstrated that 4 is 
thermodynamically more stable than the other compounds. The energy differences 
are 1.88–6.48 kcal/mol.  
 
Table S4. Molecular energies of 4 and its diastereomers. 
    








 –1136.672533 –713272.6886 0 
C2-epi-4 –1136.667796 –713269.7164 2.972260981 
C1-epi-4 –1136.662203 –713266.2068 6.481795503 
C1,C2-epi-4 –1136.669529 –713270.8041 1.884536203 





All calculations are performed under following conditions. 
# Task parameters 
Calculate optimize 
Opt_energy_convergence 1.0000e–005 
Opt_gradient_convergence  2.0000e–003 A 
Opt_displacement_convergence  5.0000e–003 A 
Opt_max_displacement  0.3000 A 
Initial_hessian improved 
Symmetry  off 
# Electronic parameters 
Spin_polarization  restricted 
Charge  0 
Basis  dnp 
Pseudopotential  none 
Functional  pbe 
Aux_density  octupole 
Integration_grid  fine 
Occupation  fermi 
Cutoff_Global  3.7000 angstrom 
Scf_density_convergence  1.0000e–006 
Scf_charge_mixing  2.0000e–001 
Scf_diis  6 pulay 









Atom X Y Z Atom X Y Z  
C 10.48937 -27.6646 5.523028 H 11.82351 -32.8406 5.731369  
C 11.42256 -28.4138 4.523993 H 10.55091 -31.1873 7.587394  
C 10.75227 -29.8608 4.543686 H 9.606884 -31.9081 6.253856  
N 10.29471 -29.9446 5.927957 H 11.04137 -25.566 5.357421  
C 10.2004 -28.7433 6.580044 H 12.01484 -26.4801 6.532626  
C 11.70045 -31.0881 4.38809 H 10.34222 -26.0434 6.926888  
C 11.75179 -31.7461 5.788336 H 12.68351 -28.764 5.992017  
C 10.47159 -31.2686 6.495947 H 11.80373 -26.6574 3.389549  
O 9.977788 -28.5798 7.7771 H 10.56687 -27.6964 2.686911  
C 11.00706 -26.3621 6.113764 H 12.42509 -29.3477 2.04594  
O 12.75204 -28.5049 5.055413 H 13.59701 -28.1989 2.695513  
C 9.525911 -29.9531 3.600221 H 12.70432 -26.4606 1.04872  
C 11.55303 -27.7085 3.174879 H 11.66081 -27.7009 0.357796  
C 12.60693 -28.2774 2.221611 H 14.736 -27.8358 0.478273  
C 12.62323 -27.5473 0.876676 H 13.79398 -27.3103 -0.92169  
C 13.77836 -27.9831 -0.04714 H 12.80306 -29.6424 -1.13942  
C 13.67748 -29.403 -0.52 H 15.42275 -30.1415 0.375631  
C 14.54888 -30.3827 -0.24187 H 15.30665 -32.0809 -1.33664  
 
 44 
C 14.44166 -31.7984 -0.71502 H 13.53016 -31.959 -1.30862  
O 8.375895 -29.8268 3.982781 H 14.42433 -32.5028 0.132272  
O 9.914059 -30.2264 2.334166 H 7.358319 -31.8278 0.722969  
C 8.901939 -30.4222 1.247503 H 7.373354 -31.4052 2.455382  
C 8.005121 -31.6114 1.585042 H 8.612608 -32.5058 1.783443  
C 8.112632 -29.1315 1.036668 H 8.794088 -28.2924 0.840508  
C 9.777506 -30.7314 0.036603 H 7.492537 -28.8968 1.908813  
H 9.533634 -27.4804 5.003471 H 7.457735 -29.2473 0.161341  
H 12.6922 -30.7642 4.051331 H 10.46076 -29.8985 -0.17188  
H 11.30082 -31.7825 3.639095 H 9.145709 -30.8978 -0.84631  
H 12.62819 -31.3848 6.345869 H 10.37818 -31.6347 0.210934  
Total energy = –1136.672533 Ha 
 
Atom X Y Z Atom X Y Z  
C 14.04103 -28.2543 5.369442 H 18.62697 -30.2153 3.510406  
C 14.55166 -28.0651 3.914233 H 17.45993 -30.3284 6.038573  
C 15.34074 -29.4346 3.639567 H 16.97209 -31.5154 4.796226  
N 15.72554 -29.8256 4.988413 H 16.07801 -27.1098 4.71503  
C 15.04646 -29.2184 6.010116 H 12.947 -26.7883 3.378129  
C 16.69402 -29.354 2.869418 H 12.74807 -28.4407 2.793111  
C 17.77777 -29.6593 3.930278 H 14.52314 -28.0095 1.038869  
C 17.03948 -30.4412 5.031878 H 14.73193 -26.377 1.681898  
O 15.25035 -29.3814 7.210907 H 12.28847 -25.9075 1.188452  
H 14.11802 -27.2869 5.88754 H 12.1562 -27.4937 0.433312  
O 15.51887 -26.9915 3.92683 H 14.08639 -25.2718 -0.47444  
 
 45 
C 14.45265 -30.5678 3.050068 H 12.49088 -25.5705 -1.17203  
C 13.48345 -27.6313 2.911012 H 13.25544 -27.8423 -1.99572  
C 13.99811 -27.184 1.539107 H 15.88743 -26.29 -1.72874  
C 12.86538 -26.674 0.644113 H 16.18216 -27.5834 -3.94056  
C 13.35113 -26.0649 -0.68591 H 15.02855 -28.8074 -3.35629  
C 13.93948 -27.0607 -1.64057 H 16.62208 -28.6168 -2.58034  
C 15.20421 -27.0707 -2.08391 H 11.44022 -32.1123 0.78841  
C 15.77999 -28.0707 -3.03763 H 11.56952 -30.4771 1.469551  
O 14.0651 -31.5216 3.703507 H 12.00379 -31.898 2.465762  
O 14.24133 -30.3829 1.729155 H 14.53034 -30.6711 -0.82425  
C 13.4652 -31.3869 0.93134 H 13.02304 -29.795 -0.47793  
C 12.0344 -31.4724 1.456715 H 12.95693 -31.4368 -1.16861  
C 13.49724 -30.7839 -0.47015 H 15.23229 -32.613 0.648463  
C 14.18501 -32.7345 0.95835 H 13.6992 -33.4142 0.244451  
C 12.61139 -28.7852 5.548204 H 14.15567 -33.1885 1.954267  
H 16.82004 -28.3637 2.418026 H 12.4648 -29.7458 5.036711  
H 16.71154 -30.0975 2.06285 H 11.86821 -28.0664 5.175415  
H 18.17043 -28.7225 4.353058 H 12.42467 -28.9459 6.618819  
Total energy = -1136.667796 Ha 
 
Atom X Y Z Atom X Y Z  
C 15.05361 -35.6805 0.078805 H 9.983213 -35.6524 0.797866  
C 14.24143 -37.0117 0.006988 H 11.933 -33.4046 0.450032  
C 12.73057 -36.539 -0.02863 H 10.9439 -34.2228 -0.78416  
N 12.81179 -35.1142 -0.33568 H 15.38615 -37.8782 -1.33511  
 
 46 
C 14.0694 -34.5739 -0.29934 H 14.44519 -37.552 2.090078  
C 11.93112 -36.5117 1.303309 H 15.71674 -38.146 1.044759  
C 10.97044 -35.3093 1.139262 H 14.05487 -39.7931 0.029369  
C 11.61613 -34.3847 0.069065 H 12.87953 -39.3045 1.226813  
O 14.33188 -33.3784 -0.41074 H 15.64943 -40.4879 1.8629  
H 15.84631 -35.7266 -0.68377 H 14.13165 -41.3839 1.854509  
O 14.45603 -37.5969 -1.29917 H 14.83219 -39.0805 3.778678  
C 11.90514 -37.3522 -1.05787 H 14.85826 -40.8039 4.141358  
C 14.61976 -38.0144 1.108219 H 12.31999 -40.9009 3.755721  
C 13.95942 -39.3932 1.048753 H 12.85109 -37.9976 4.601084  
C 14.56535 -40.3888 2.045536 H 10.70048 -38.6022 5.885702  
C 14.34628 -40.0382 3.533245 H 10.32408 -39.8241 4.646242  
C 12.89884 -39.9828 3.924269 H 10.28713 -38.0885 4.249869  
C 12.27104 -38.915 4.436845 H 8.691225 -37.9314 -3.46357  
C 10.82498 -38.8623 4.822108 H 8.841541 -36.8135 -2.08956  
O 11.64009 -38.5298 -0.89055 H 9.473411 -38.4823 -1.95898  
O 11.51939 -36.585 -2.09377 H 11.45912 -35.5786 -4.47194  
C 10.68047 -37.1513 -3.19283 H 9.983895 -35.1273 -3.58046  
C 9.342512 -37.6284 -2.63173 H 9.876487 -36.2313 -4.97608  
C 10.48951 -35.9459 -4.11071 H 12.42299 -37.8949 -4.248  
C 11.44598 -38.2628 -3.90634 H 10.87052 -38.5862 -4.7851  
C 15.69592 -35.2924 1.418745 H 11.60187 -39.1241 -3.24876  
H 12.62958 -36.3298 2.130932 H 14.95092 -35.2165 2.224067  
H 11.41313 -37.4568 1.502925 H 16.46399 -36.0142 1.728322  
H 10.81752 -34.7848 2.091274 H 16.16606 -34.3068 1.307728  




Atom X Y Z Atom X Y Z  
C 9.474507 -38.1832 -0.51487 H 9.860445 -33.0972 0.456619  
C 9.645243 -37.6055 0.920853 H 10.88191 -34.716 -1.88441  
C 9.470247 -36.0126 0.719444 H 9.292989 -33.962 -1.64594  
N 9.574493 -35.8524 -0.72381 H 8.587065 -37.5813 2.567575  
C 9.625475 -36.9993 -1.46444 H 11.21564 -37.3484 2.394603  
C 10.54693 -35.0203 1.226918 H 11.80708 -37.6554 0.757347  
C 10.55417 -33.8986 0.163442 H 10.96271 -40.0626 0.989059  
C 10.07771 -34.5534 -1.15304 H 10.48532 -39.6927 2.641974  
O 9.810907 -37.0515 -2.67885 H 13.34442 -39.5343 1.511873  
C 8.166803 -38.9356 -0.78126 H 12.89647 -39.0497 3.150323  
O 8.620582 -38.1348 1.763929 H 13.85498 -41.2751 3.242667  
C 8.107405 -35.5912 1.305887 H 12.13983 -41.3697 3.65546  
C 11.03569 -37.9518 1.488514 H 11.64002 -42.3503 1.359816  
C 11.20926 -39.4291 1.856031 H 14.63447 -42.9093 1.69542  
C 12.63262 -39.7379 2.328918 H 12.40235 -44.1186 -0.11269  
C 12.84104 -41.1846 2.822127 H 13.74864 -45.0581 0.58172  
C 12.65139 -42.2337 1.765759 H 14.07486 -43.8455 -0.65823  
C 13.6238 -43.0206 1.284416 H 4.083303 -36.03 1.645691  
C 13.44739 -44.0603 0.222368 H 5.611208 -36.25 2.540387  
O 7.955272 -35.4785 2.51884 H 5.317258 -37.1558 1.031086  
O 7.182906 -35.3793 0.362697 H 6.194471 -32.9317 0.846336  
C 5.763655 -35.055 0.721553 H 6.206832 -33.7706 2.425689  
C 5.165131 -36.1954 1.541386 H 4.663418 -33.427 1.602721  
 
 48 
C 5.713193 -33.7135 1.449435 H 5.584004 -34.1875 -1.26176  
C 5.099895 -34.9588 -0.64932 H 4.040473 -34.6969 -0.52842  
H 10.30964 -38.8619 -0.74122 H 5.166546 -35.917 -1.18116  
H 11.52269 -35.5199 1.240991 H 8.085878 -39.8199 -0.13702  
H 10.33384 -34.6557 2.238058 H 8.149549 -39.2511 -1.8331  
H 11.5469 -33.4418 0.061512 H 7.293395 -38.2981 -0.59221  
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Biphasic CuAAC Reaction  






While the traditional thermal azide-alkyne 1,3-dipolar cycloaddition reaction 
requires prolonged heating at elevated temperatures and results in mixtures of both 
1,4- and 1,5-substituted triazole regioisomers,
1
 the Cu(I) catalyzed version 
(CuAAC) provides only the 1,4-regioisomer under relatively mild conditions.
2
 
Since its discovery, CuAAC has emerged as the archetypical example of “click 
chemistry”,
3
 and has found widespread application in many areas such as drug 
discovery, material science, and bioconjugation.
4
 This broad application was made 
possible in part by the advent of new reaction conditions that are more efficient and 
adaptable than the original CuAAC conditions.
5  
The original CuAAC conditions suggested by Sharpless use an in situ generated 
Cu(I) catalyst derived from the reaction of CuSO4·5H2O and sodium ascorbate, and 
a mixture of water and t-BuOH.
2a 
The general issues in the development of new 
CuAAC conditions are generating the effective Cu(I) catalyst and maintaining high 
levels of the catalytically active Cu(I) during the reaction. As a consequence, a 
wide range of Cu(I) sources have been introduced, and various Cu ligands were 
developed to prevent the formation of unreactive polynuclear Cu(I) acetylides and 
increase the thermodynamic stability of Cu(I).
5b,6,7
 Alternatively, a variety of 






Another important issue has been the different solubility preferences of the Cu(I) 
catalyst and substrates.
9
 As one may notice, most of the copper salts have limited 
solubility in organic solvents
10
 while the substrates of interest in organic synthesis 
generally have a high organic solubility. To solve this problem, the use of organic-







these ligand chelated Cu(I) reagents exhibited better organic solubility and high 
reactivity, they possess some drawbacks. For example, phosphine based Cu(I) 
complexes have the intrinsic risk of the Staudinger reduction of azide.
5c
 In some 
cases, these catalysts require harsh reaction conditions, such as elevated 
temperatures. In addition, the lengthy and complex procedures for catalysts 
preparation reduce the wide application of such catalysts. 
Another way of solving the problem derived from the different solubility 
preferences is the careful choice of solvent systems.
5a
 Most commonly, the reaction 
is performed in a mixture of water and water-miscible organic solvent, which 
facilitates solvation of hydrophobic substrates while still retaining the advantages 
of water. Organic solvents of intermediate polarity, such as THF, acetone, pyridine, 
CH3CN, and DMSO, are often employed when partially organic soluble CuI or 




system composed of water and organic solvent was also reported to be effective to 
produce the triazole products with or without a ligand.
12
 Although many solvent 
systems are available, finding the optimum solvent is still a case-to-case basis 
because there is no obvious correlation between which solvent is used and 
performance of the reaction.  
Given our interest in developing reliable, general reaction conditions for CuAAC 
in organic synthesis, we sought to explore the possibility of applying the concept of 
phase transfer catalysis (PTC) as a solution for the different solubility preferences. 
PTC is an efficient and widely used method for promoting reactions between 
reaction partners that are present in two immiscible phases.
13
 However, the concept 
of PTC has rarely been applied to CuAAC reactions,
14
 and its potential use has not 
been sufficiently explored. One of the few investigations employing this concept is 
the utilization of α-cyclodextrin in water medium.
14a
 Although this reaction system 
quickly provides the product by making a host-guest complex within the 
hydrophobic cyclodextrin cavity, there are some substrate limitations due to the 
capacity allowances of cyclodextrins.
15
 Polyethylene glycol 400 (PEG-400) has 
been employed as a phase transferring agent in a one-pot multi-component CuAAC 
reaction in water medium.
14b,c
 In this case, a large excess of PEG-400 was used as 
like a co-solvent. 




delivered to the water medium, we employed an aqueous/organic two-phase 
solvent system and planned to transfer copper from the aqueous phase to the 
organic phase where the reaction occurs. We envisioned that the aqueous biphasic 
reaction system would be advantageous for a broad range of substrates and would 
be highly generalizable if the biphasic CuAAC reactions could be facilitated by a 
phase transfer agent. Herein, we report our studies on this subject and describe new 
CuAAC reaction conditions which are highly efficient, especially when a lipophilic 





II. Results and Discussion 
 
Our working hypothesis for the phase transfer agent assisted CuAAC reaction is 
shown in Figure 1. The in situ generated Cu(I) catalyst produced by the reaction of 
Cu(II) and sodium ascorbate in aqueous phase would be ferried into the organic 
phase by a phase transfer agent as a complex form.
16
 Similarly to other organic-
soluble Cu(I) complexes, the relocated Cu(I) species would promote the CuAAC 
reactions in the organic phase. During the reaction process, Cu(I) can be 
inadvertently oxidized to Cu(II). In aqueous phase in which sodium ascorbate is 
dissolved, these oxidized Cu(II) species can revert back to the catalytically active 
Cu(I) species,
17
 which are able to reenter the cycle with the help of the phase 
transfer agent.  
 
Figure 1. Schematic representation of phase transfer agent assisted CuAAC reaction. 




encapsulate Cu(I) in the aqueous phase or at the interface to deliver it to the 
organic phase. In addition, it is advantageous if they are able to be coordinated with 
Cu(I) during the reaction to enhance the rate of reaction and to protect the Cu(I) 
from oxidation. 
 
Figure 2. Structures of tris(triazolylmethyl)amine ligands (1a–1d). 
To identify phase transfer agents that fulfill the above conditions, we surveyed 
several types of ligands which have been devised to promote the Cu(I) catalyzed 
triazole formation. This effort resulted in the selection of tris(triazolylmethyl)amine 
ligands that are easily available and consist of several variants with different 
physicochemical properties.
7a,18
 Four typical tris(triazolylmethyl)amine ligands 
(1a–1d, Figure 2) with different functional groups and log P values were chosen 
for the first step of the development. Benzyl azide (2a) and phenyl acetylene (3a) 
were chosen as a CuAAC reaction partners, and water soluble CuSO4·5H2O (0.5 
mol%) and sodium ascorbate (1.5 mol%) were used to generate the Cu(I) in situ. A 




Table 1. Effects of tris(triazolylmethyl)amine ligands on the CuAAC reaction.
a 
 
Entry Ligand Time (min) Yield
 b
 (%) 
1 none 240 20 
2 1a 20 100 
3 1b 40 100 
4 1c 240 47 
5 1d 240 3 
a Reaction conditions: 2a (0.50 mmol), 3a (0.55 mmol), CuSO4·5H2O (0.5 mol%), Na 
ascorbate (1.5 mol%), and ligand (0.5 mol%) in CH2Cl2/H2O (1:1) (1 mL) at rt. 
b 
Determined by 1H NMR analysis using 1,1,2,2-tetrachloroethane as an internal standard. 
When the reaction was performed without a ligand for 240 min (entry 1), most 
of the starting materials remained intact and the desired product was obtained in 
poor yield (20%). However, in the presence of TTTA (1a), the reaction was 
completed within 20 min with the formation of product in nearly quantitative yield 
(entry 2). TBTA (1b) increased the reaction rate such that the reaction was 
completed within 40 min (entry 3).
19
 BTTAA (1c) was far less effective in 
accelerating the reaction (entry 4). The most hydrophilic ligand THPTA (1d) 
significantly retarded the reaction, resulting in only 3% product yield even after 
240 min (entry 5).  







Entry Ligand Clog P
b
 Cu content (ppb)
c
 
1 none - 78 
2 1a 1.1 70330 
3 1b 2.7 39475 
4 1c –0.37 125 
5 1d –3.7 128 
a Conditions: CuSO4·5H2O (0.0025 mmol), Na ascorbate (0.0075 mmol), and ligand 
(0.0025 mmol) in CH2Cl2/H2O (1:1) (1 mL) at rt for 30 min. 
b Clog P values were 
calculated using ChemBioDraw Ultra 13.0. c Determined by ICP-MS analysis. 
To verify whether the observed reaction rates were related to the phase transfer 
activity of tris(triazolylmethyl)amine ligands, we used ICP-MS analysis to measure 
the copper content in the organic layer of the substrate-blank biphasic reaction 
system. As shown in Table 2, the copper content in the organic layer was very low 
(78 ppb) without any ligand (entry 1). In the presence of TTTA (1a, Clog P = 1.1), 
the copper content was increased approximately 900 times (entry 2). TBTA (1b, 
Clog P = 2.7) also resulted in an increase of copper content by approximately 500 
times (entry 3). The more hydrophilic ligands 1c and 1d did not cause a significant 
increase in the copper content (entries 4 and 5). This result indicated that the 
tris(triazolylmethyl)amine ligands with appropriate hydrophilic-lipophilic balances 
are able to extract copper from the aqueous phase to the organic phase, thereby 
accelerating the rate of the CuAAC reaction. 




of TTTA (1a) between CH2Cl2 and H2O by 
1
H NMR analysis. To our surprise, 
although the calculated log P value for 1a is 1.1, only a negligible amount of 1a 
was resided in the aqueous layer while the overwhelming majority of 1a was 
detected in the CH2Cl2 layer. This result suggested that the complexation between 
1a and Cu(I) might occur mostly at or near the interface between CH2Cl2 and H2O, 








Entry Solvent  Time (min) Yield (%)
b
 
1 CHCl3/H2O (1:1) 25 100 
2 toluene/H2O (1:1) 50 97 
3 CH2Cl2/H2O (1:1) 15 100 
4 t-BuOH/H2O (2:1) 360 99 
5 H2O 360 78 
6 CH2Cl2 360 <1 
a Reaction conditions: 2b (0.50 mmol), 3a (0.55 mmol), CuSO4·5H2O (0.5 mol%), Na 
ascorbate (1.5 mol%), and 1a (0.5 mol%) in solvent (1 mL) at rt. b Determined by 1H 
NMR analysis using 1,1,2,2-tetrachloroethane as an internal standard. 
Toluene and CHCl3 can also be used as the organic phase of the biphasic system 




phenyl acetylene (3a) in biphasic CHCl3/H2O medium was completed in 25 min in 
the presence of 1a (entry 1), and the reaction in toluene/H2O was completed in 50 
min (entry 2). Although the reaction in these solvent systems was slower than 
reactions performed in the CH2Cl2/H2O solvent system (entry 3), the necessary 
reaction time was still short and the yield was very high. The corresponding 
reaction in the monophasic t-BuOH/H2O solvent system was much less efficient 
and reached full conversion in 360 min (entry 4). When water was used as the only 
solvent, full conversion was not reached even after 360 min primarily because of 
the limited solubility of substrates (entry 5). The reaction in only CH2Cl2 solvent 
provided a trace amount of the product in 360 min because of the limited solubility 
of CuSO4·5H2O and sodium ascorbate (entry 6). 
The scope of applicability of the phase transfer agent assisted CuAAC reaction 
was explored with 0.5 mol% of TTTA (1a) in a biphasic CH2Cl2/H2O medium 
containing CuSO4·5H2O and ascorbate (0.5 and 1.5 mol%, respectively; conditions 
A). First, we applied various types of azides to the reaction system. As shown in 
Table 4, the azide structure has no significant effect on the reaction rates. All of the 
reactions proceeded efficiently and were completed in less than 15 min, with 
excellent isolated yields (entries 1–5). However, the effects of alkyne structures on 
the reaction rates were significant. Alkynes with an ester group or a phenyl group 






















1 cyclohexyl (2c) Ph (3a) A 15 4c 97 
2 C2H5OCOCH2 (2d) Ph (3a) A 5 4d 98 
3 p-NO2C6H4CH2 (2e) Ph (3a) A 10 4e 96 




Ph (3a) A 10 4g 99 
6 PhCH2 (2a) CO2C2H5 (3b) A 15 4h 98 
7 PhCH2 (2a) p-CH3OC6H4 (3c) A 20 4i 100 
8 PhCH2 (2a) CH2NHBoc (3d) A 30 4j 95 
9 PhCH2 (2a) CH2OH (3e) A 50 4k 99 
10 PhCH2 (2a) 
cyclohexane-1-ol 
(3f) 
A 40 4l 95 
11 PhCH2 (2a) t-Bu (3g) A 50 4m 98 
12 PhCH2 (2a) n-Hex (3h) B 40 4n 98 
13 PhCH2 (2a) cyclohexyl (3i) B 50 4o 100 
14 PhCH2 (2a) CO2H (3j) B 20 4p 91 
15 PhCH2 (2a) CH2NH2 (3k) B 180 4q 97 
16 NH2C2H4 (2h) Ph (3a) B 20 4r 98 
17 NH2C6H12 (2i) Ph (3a) B 120 4s 93 
18 CH3NHC6H12 (2j) Ph (3a) B 50 4t 96 
a Reaction conditions: 2 (0.50 mmol), 3 (0.55 mmol), 1a (0.5 mol%), with conditions A or B in 
CH2Cl2/H2O (1:1) (1 mL) at rt. 
b A: CuSO4·5H2O (0.5 mol%), Na ascorbate (1.5 mol%). B: 
CuSO4·5H2O (1.5 mol%), Na ascorbate (4.5 mol%). 




min in excellent yields (entries 6 and 7). The N-Boc group at the propargylic 
position of the alkyne substrate did not affect the reaction rates (entry 8). Propargyl 
alcohols were also suitable for this reaction system, yielding product in less than 50 
min (entries 9 and 10). The reaction of the t-butyl substituted alkyne was 
completed in 50 min (entry 11). However, the reaction of the n-hexyl or cyclohexyl 
substituted alkynes was not completed within the same time. These substrates 
required an increase in copper and sodium ascorbate loading (1.5 and 4.5 mol%, 
respectively; conditions B) for completion within 50 min (entries 12 and 13). The 
cycloadditions of propynoic acid also proceeded efficiently under these higher 
copper loading conditions (entry 14). 
Noteworthy was the result obtained in the biphasic CuAAC reaction of 
propargyl amine (entry 15) because the CuAAC reaction generally fails or gives 
low yield in the presence of free amino groups as a consequence of the 
coordination between the Cu(I) ion and the amino group.
7a,21
 Under higher reagent 
loading conditions, the triazole product 4q was successfully obtained in 97% yield. 
In addition, the reactions between free amine containing azides 2h–j and the 
phenyl acetylene (3a) proceeded efficiently in this reaction system (entries 16–18). 
We demonstrated the utility and efficiency of the phase transfer agent assisted 
biphasic CuAAC reaction by applying it to the synthesis of an immunostimulant α-
GalCer analog 5.
22





Scheme 1. Efficient synthesis of α-GalCer analog 5 using the phase transfer agent assisted 
CuAAC reaction. 
CuAAC reaction of azide 7 with 6 under the conventional reaction system was not 
met with great success. For example, when the reaction was performed in 
monophasic t-BuOH/H2O solvent system, the triazole product 5 was obtained in 
only 20% after 24 h even in the presence of TTTA (1a). However, under the 
presented biphasic system, we successfully obtained 5 in 92% yield in a short 






In summary, we have developed a phase transfer agent assisted biphasic CuAAC 
reaction system. A biphasic reaction media consisting of water and an organic 
solvent ensures a complete dissolution of reagents and substrates, thus broadening 
the scope of possible substrates. Among the tested tris(triazolylmethyl)amine Cu 
ligands, TTTA (1a) and TBTA (1b) afforded the expected phase transfer activity. 
The developed biphasic reaction system is highly efficient, especially when a 
lipophilic substrate is involved. The present system is widely applicable to 
substrates with various functionalities including a free amino group, making the 






IV-1. General.  
 
All chemicals were reagent grade and used as purchased. The reactions were 
monitored with TLC analysis using silica gel 60 F-254 thin layer plates. 
Compounds on the TLC plates were sprayed with either potassium permanganate 
or phosphomolybdic acid and visualized under UV light. Flash column 
chromatography was conducted on silica gel 60 (230–400 mesh). Optical rotations 
were measured using a sodium lamp (D line 589.3 nm). Melting points were 
measured using an electrothermal capillary melting point apparatus and are 
uncorrected. 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectra were recorded 
in δ units relative to the deuterated solvent. IR spectra were measured on a Fourier 
Transform Infrared spectrometer. High-resolution mass spectra (HRMS) were 
recorded using FAB. Inductively coupled plasma mass spectrometry (ICP-MS) 





IV-2. Experimental procedure and spectroscopic data analysis 
Preparation of the Starting Materials.  







 and alkyne 3d
26
 was also prepared according to the 
procedures in the literature. The NMR data were in agreement with those published 
























and tert-butyl prop-2-ynylcarbamate (3d).
26 
Measurement of partition ratio of TTTA (1a) between CH2Cl2 and H2O. 
In a vial fitted with a screw cap, TTTA (1a, 85.6 mg, 0.2 mmol) was dissolved in 
CH2Cl2/H2O (1:1, 2 mL) and stirred at rt for 1 or 12 hr. After phase separation, 0.5 
mL of each layer was carefully sampled and the solvents were evaporated. The 1a 
in each residue was measured by 
1
H NMR in CDCl3 using 1,1,2,2-
tetrachloroethane as an internal standard. In the sample taken from the H2O layer, 
no peak of 1a was identified.  
General procedure for CuAAC reactions. 




(50 L, 50 mM stock solution in DDW, 0.5 mol%), TTTA (1a, 50 L, 50 mM 
stock solution in CH2Cl2, 0.5 mol%), and sodium ascorbate (50 L, 150 mM stock 
solution in DDW, 1.5 mol%) were added to a mixture of azide 2 (0.5 mmol, 1.0 
equiv) and acetylene 3 (0.55 mmol, 1.1 equiv) in DDW (0.40 mL) and CH2Cl2 
(0.45 mL). The reaction was allowed to proceed at rt and monitored by TLC. After 
total consumption of the starting azide, the reaction mixture was poured into 
saturated NH4Cl aqueous solution (10 mL). The aqueous layer was extracted with 
CH2Cl2 (2 × 10 mL). 
For the carboxylic acid containing compound 4p, the mixture was acidified to pH 
1 with 1N HCl aqueous solution and extracted with CH2Cl2 (5 × 10 mL). 
For the free amine containing compounds 4q–4r, the reaction mixture was poured 
into 25 % NH4OH aqueous solution (10 mL) and extracted with CH2Cl2 (3 × 10 
mL). 
The combined organic layers were dried over MgSO4, and concentrated in vacuo. 
When required, the product was purified by flash column chromatography on silica 
gel. 
1-Benzyl-4-phenyl-1H-1,2,3-triazole (4a): white solid (117.3 mg, 100%); m.p. 
130–132 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.79–7.77 (m, 2H), 7.66 (s, 1H), 7.28–
7.26 (m, 8H), 5.51 (s, 2H); 
13
C NMR (100 MHz, CDCl3) δ 148.0, 134.6, 130.4, 






) υmax 3141, 3027, 2976, 1468, 1449, 1361, 1222, 1140, 1073, 1044, 766, 727, 
693; HRMS (FAB): calcd. for C15H14N3 [M+H]
+
 236.1188, found 236.1189.  
1-Octyl-4-phenyl-1H-1,2,3-triazole (4b): white solid (128.6 mg, 100%); m.p. 
78–80 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.80–7.78 (m, 2H), 7.72 (s, 1H), 7.38–
7.34 (m, 2H), 7.29–7.25 (m, 1H), 4.31 (t, J = 7.2 Hz, 2H), 1.91–1.84 (m, 2H), 
1.28–1.21 (m, 10H), 0.83 (t, J = 6.7 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 147.5, 
130.6, 128.6 (2C), 127.9, 125.5 (2C), 119.4, 50.2, 31.5, 30.2, 28.9, 28.8, 26.3, 22.4, 
13.9; IR (neat, cm
-1
) υmax 3120, 3092, 3064, 2954, 2917, 2849, 1484, 1463, 1356, 
1215, 1190, 1078, 1051, 976, 839, 760, 693; HRMS (FAB): calcd. for C16H24N3 
[M+H]
+
 258.1970, found 258.1976.  
1-Cyclohexyl-4-phenyl-1H-1,2,3-triazole (4c): white solid (110.2 mg, 97%); 
m.p. 107–108 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.80–7.78 (m, 2H), 7.75 (s, 1H), 
7.37–7.33 (m, 2H), 7.27–7.23 (m, 1H), 4.39 (tt, J = 11.8, 3.7 Hz, 1H), 2.17–2.14 
(m, 2H), 1.87–1.67 (m, 5H), 1.44–1.19 (m, 3H); 
13
C NMR (100 MHz, CDCl3) δ 
147.0, 130.7, 128.6 (2C), 127.7, 125.4 (2C), 117.3, 59.9, 33.3 (2C), 24.94 (2C), 
24.89; IR (neat, cm
-1
) υmax 3126, 2936, 2854, 1480, 1452, 1374, 1223, 1054, 1000, 
894, 826, 761, 691; HRMS (FAB): calcd. for C14H18N3 [M+H]
+
 228.1501, found 
228.1503.  
Ethyl 2-(4-phenyl-1H-1,2,3-triazol-1-yl)acetate (4d): white solid (113.3 mg, 
98%); m.p. 93–94 °C; 
1




2H), 7.38–7.35 (m, 2H), 7.30–7.26 (m, 1H), 5.13 (s, 2H), 4.19 (q, J = 7.2 Hz, 2H), 
1.23 (t, J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 166.1, 147.7, 130.2, 128.6 
(2C), 127.9, 125.5 (2C), 121.1, 62.1, 50.6, 13.7; IR (neat, cm
-1
) υmax 3135, 2948, 
1752, 1465, 1442, 1346, 1214, 1197, 1074, 1014, 763, 692; HRMS (FAB): calcd. 
for C12H14N3O2 [M+H]
+
 232.1086, found 232.1087.  
1-(4-Nitrobenzyl)-4-phenyl-1H-1,2,3-triazole (4e): white solid (134.4 mg, 
96%); m.p. 157–159 °C; 
1
H NMR (400 MHz, CDCl3) δ 8.20–8.18 (m, 2H), 7.79–
7.74 (m, 3H), 7.42–7.29 (m, 5H), 5.66 (s, 2H); 
13
C NMR (100 MHz, CDCl3) δ 
148.6, 148.0, 141.7, 130.1, 128.9 (2C), 128.5 (2C), 128.4, 125.7 (2C), 124.3 (2C), 
119.7, 53.1; IR (neat, cm
-1
) υmax 3127, 3083, 1606, 1517, 1347, 1222, 1077, 1045, 
861, 803, 761, 729, 690; HRMS (FAB): calcd. for C15H13N4O2 [M+H]
+
 281.1039, 
found 281.1034.  
1-(4-Bromobenzyl)-4-phenyl-1H-1,2,3-triazole (4f): white solid (150.4 mg, 
96%); m.p. 150–152 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.78–7.76 (m, 2H), 7.66 (s, 
1H), 7.48–7.45 (m, 2H), 7.39–7.37 (m, 2H), 7.31–7.27 (m, 1H), 7.14–7.12 (m, 2H), 
5.47 (s, 2H); 
13
C NMR (100 MHz, CDCl3) δ 148.3, 133.7, 132.2 (2C), 130.3, 129.6 
(2C), 128.8 (2C), 128.2, 125.6 (2C), 122.8, 119.5, 53.4; IR (neat, cm
-1
) υmax 3107, 
3083, 1483, 1461, 1431, 1350, 1219, 1073, 1047, 1010, 799, 961, 687; HRMS 
(FAB): calcd. for C15H13BrN3 [M+H]
+
 314.0293, found 314.0292.  




99%); m.p. 139–140 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.77–7.75 (m, 2H), 7.62 (s, 
1H), 7.35 (t, J = 7.7 Hz, 2H), 7.28–7.21 (m, 3H), 6.86 (d, J = 8.6 Hz, 2H), 5.44 (s, 
2H), 3.76 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 159.8, 147.9, 130.5, 129.5 (2C), 
128.6 (2C), 128.0, 126.6, 125.5 (2C), 119.3, 114.4 (2C), 55.2, 53.6; IR (neat, cm
-1
) 
υmax 3107, 3083, 1483, 1461, 1219, 1073, 1010, 816, 799, 761, 687; HRMS (FAB): 
calcd. for C16H16N3O [M+H]
+
 266.1293, found 266.1291.  
Ethyl 1-benzyl-1H-1,2,3-triazole-4-carboxylate (4h): white solid (113.3 mg, 
98%); m.p. 84–86 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.98 (s, 1H), 7.25–7.17 (m, 
5H), 5.48 (s, 2H), 4.25 (q, J = 7.2 Hz, 2H), 1.24 (t, J = 7.2 Hz, 3H); 
13
C NMR (100 
MHz, CDCl3) δ 160.3, 140.1, 133.7, 128.9 (2C), 128.6, 127.9 (2C), 127.2, 60.8, 
54.0, 13.9; IR (neat, cm
-1
) υmax 3126, 2983, 1715, 1539, 1368, 1226, 1044, 1022, 
776, 716, 693; HRMS (FAB): calcd. for C12H14N3O2 [M+H]
+
 232.1086, found 
232.1088. 
1-Benzyl-4-(4-methoxyphenyl)-1H-1,2,3-triazole (4i): white solid (132.3 mg, 
100%); m.p. 142–144 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.71–7.69 (m, 2H), 7.56 
(s, 1H), 7.37–7.27 (m, 5H), 6.92–6.89 (m, 2H), 5.52 (s, 2H), 3.80 (s, 3H); 
13
C 
NMR (100 MHz, CDCl3) δ 159.5, 147.9, 134.7, 129.0 (2C), 128.6, 127.9 (2C), 
126.9 (2C), 123.2, 118.7, 114.1 (2C), 55.2, 54.0; IR (neat, cm
-1
) υmax 3138, 3040, 
2949, 2838, 2098, 1614, 1557, 1495, 1454, 1436, 1349, 1249, 1170, 1070, 1027, 
973, 832, 794, 717; HRMS (FAB): calcd. for C16H16N3O [M+H]
+





tert-Butyl ((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)carbamate (4j): light 
yellow solid (137.0 mg, 95%); m.p. 91–93 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.40 
(s, 1H), 7.37–7.23 (m, 5H), 5.48 (s, 2H), 5.04 (brs, 1H, NH), 4.34 (d, J = 5.9 Hz, 
2H), 1.39 (s, 9H); 
13
C NMR (100 MHz, CDCl3) δ 155.7, 145.7, 134.5, 128.9 (2C), 
128.5, 127.8 (2C), 121.7, 79.3, 53.9, 35.9, 28.2 (3C); IR (neat, cm
-1
) υmax 3405, 
3111, 3063, 2978, 2954, 1688, 1515, 1454, 1268, 1169, 1123, 1054, 796, 717, 695; 
HRMS (FAB): calcd. for C15H21N4O2 [M+H]
+
 289.1665, found 289.1666.  
(1-Benzyl-1H-1,2,3-triazol-4-yl)methanol (4k): white solid (93.4 mg, 99%); 
m.p. 77–79 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.43 (s ,1H), 7.31–7.28 (m, 3H), 
7.21–7.19 (m, 2H), 5.42 (s, 2H), 4.67 (s, 2H), 3.71 (brs, 1H, OH); 
13
C NMR (100 
MHz, CDCl3) δ 148.2, 134.4, 129.0 (2C), 128.6, 128.0 (2C), 121.8, 55.9, 54.0; IR 
(neat, cm
-1
) υmax 3252, 3140, 2934, 1457, 1222, 1129, 1036, 1012, 837, 788, 717, 
691; HRMS (FAB): calcd. for C10H12N3O [M+H]
+
 190.0980, found 190.0980.  
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)cyclohexan-1-ol (4l): white solid (122.1 mg, 
95%); m.p. 125–126 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.35 (s, 1H), 7.31–7.25 
(3H), 7.19–7.17 (m, 2H), 5.40 (s, 2H), 3.05 (brs, 1H, OH), 1.91–1.25 (m, 10H); 
13
C 
NMR (100 MHz, CDCl3) δ 156.0, 134.6, 128.8 (2C), 128.4, 127.9 (2C), 119.5, 
69.3, 53.8, 37.9 (2C), 25.2, 21.7 (2C); IR (neat, cm
-1
) υmax 3293, 2933, 2856, 1497, 






 258.1606, found 258.1599.  
1-Benzyl-4-(tert-butyl)-1H-1,2,3-triazole (4m): white solid (105.1 mg, 98%); 
m.p. 84–86 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.29–7.24 (m, 3H), 7.19–7.17 (m, 
2H), 7.15 (s, 1H), 5.39 (s, 2H), 1.25 (s, 9H); 
13
C NMR (100 MHz, CDCl3) δ 157.8, 
134.9, 128.7 (2C), 128.2, 127.7 (2C), 118.3, 53.6, 30.5, 30.1 (3C); IR (neat, cm
-1
) 
υmax 3119, 2961, 2865, 1531, 1495, 1457, 1361, 1341, 1231, 1202, 1051, 821, 713, 
673; HRMS (FAB): calcd. for C13H18N3 [M+H]
+
 216.1501, found 216.1498.  
1-Benzyl-4-hexyl-1H-1,2,3-triazole (4n): white solid (119.0 mg, 98%); m.p. 
52–54 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.35–7.29 (m, 3H), 7.23–7.21 (m, 2H), 
7.15 (s, 1H), 5.45 (s, 2H), 2.65 (t, J = 7.8 Hz, 2H), 1.64–1.56 (m, 2H), 1.34–1.25 
(m, 6H), 0.83 (t, J = 6.7 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 148.6, 134.9, 
128.8 (2C), 128.3, 127.7 (2C), 120.4, 53.6, 31.3, 29.1, 28.7, 25.5, 22.3, 13.8; IR 
(neat, cm
-1
) υmax 3112, 3065, 2957, 2919, 2853, 1553, 1493, 1456, 1433, 1325, 
1212, 1130, 1051, 1029, 856, 703, 691; HRMS (FAB): calcd. for C15H22N3 [M+H]
+
 
244.1814, found 244.1816.  
1-Benzyl-4-cyclohexyl-1H-1,2,3-triazole (4o): white solid (120.4 mg, 100%); 
m.p. 109–111 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.37–7.31 (m, 3H), 7.24–7.22 (m, 
2H), 7.12 (s, 1H), 5.46 (s, 2H), 2.72–2.71 (m, 1H), 2.01–1.99 (m, 2H), 1.77–1.66 
(m, 3H), 1.37–1.29 (m, 4H), 1.22–1.18 (m, 1H); 
13
C NMR (100 MHz, CDCl3) δ 




25.8; IR (neat, cm
-1
) υmax 3121, 2925, 2851, 1540, 1495, 1450, 1264, 1208, 1128, 
1049, 821, 754, 721, 699; HRMS (FAB): calcd. for C15H20N3 [M+H]
+
 242.1657, 
found 242.1660.  
1-Benzyl-1H-1,2,3-triazole-4-carboxylic acid (4p): white solid (92.1 mg, 
91%); m.p. 184–185 °C; 
1
H NMR (400 MHz, (CD3)2SO) δ 12.92 (brs, 1H, CO2H) 
8.75 (s, 1H), 7.40–7.33 (m, 5H), 5.64 (s, 2H); 
13
C NMR (100 MHz, (CD3)2SO) δ 
161.6, 140.1, 135.6, 128.9, 128.8 (2C), 128.2, 128.0 (2C), 53.0; IR (neat, cm
-1
) υmax 
3115, 2556, 1681, 1540, 1495, 1425, 1232, 1049, 944, 895, 783, 714, 687; HRMS 
(FAB): calcd. for C10H10N3O2 [M+H]
+
 204.0773, found 204.0767.  
(1-Benzyl-1H-1,2,3-triazol-4-yl)methanamine (4q): white solid (91.2 mg, 
97%); m.p. 106–109 °C; 
1
H NMR (400 MHz, (CD3)2SO) δ 7.92 (s, 1H), 7.39–7.30 
(m, 5H), 5.56 (s, 2H), 3.75 (s, 2H), 2.31 (brs, 2H, NH2); 
13
C NMR (100 MHz, 
(CD3)2SO) δ 150.1, 136.2, 128.7 (2C), 128.0, 127.9 (2C), 121.8, 52.7, 37.2; IR 
(neat, cm
-1
) υmax 3345, 3137, 2917, 1604, 1494, 1454, 1328, 1212, 1124, 1050, 898, 
802, 726, 693, 668; HRMS (FAB): calcd. for C10H13N4 [M+H]
+
 189.1140, found 
189.1135.  
2-(4-Phenyl-1H-1,2,3-triazol-1-yl)ethan-1-amine (4r): white solid (92.0 mg, 
98%); m.p. 75–77 °C; 
1
H NMR (400 MHz, (CD3)2SO) δ 8.54 (s, 1H), 7.84 (d, J = 
7.3 Hz, 2H), 7.44 (t, J = 7.5 Hz, 2H), 7.32 (t, J = 7.3 Hz, 1H), 4.36 (t, J = 6.2 Hz, 
2H), 3.02 (m, 2H); 
13




127.7, 125.1 (2C), 121.6, 52.7, 41.7; IR (neat, cm
-1
) υmax 3338, 3125, 2952, 1461, 
1217, 1075, 1039, 828, 760, 693; HRMS (FAB): calcd. for C10H13N4 [M+H]
+
 
189.1140, found 189.1135.  
6-(4-Phenyl-1H-1,2,3-triazol-1-yl)hexan-1-amine (4s): white solid (113.7 mg, 
93%); m.p. 68–71 °C; 
1
H NMR (400 MHz, C5D5N) δ 8.41 (s, 1H), 8.17 (d, J = 7.4 
Hz, 2H), 7.46 (t, J = 7.6 Hz, 2H), 7.33 (t, J = 7.4 Hz, 1H), 4.36 (t, J = 7.1 Hz, 2H), 
2.65 (t, J = 6.8 Hz, 2H), 1.85–1.78 (m, 2H), 1.37–1.21 (m, 6H); 
13
C NMR (100 
MHz, C5D5N) δ 147.7, 132.0, 129.3 (2C), 128.2, 126.0 (2C), 121.0, 50.2, 42.1, 
33.3, 30.4, 26.4 (2C); IR (neat, cm
-1
) υmax 3286, 3118, 3008, 2924, 2849, 1578, 
1483, 1462, 1215, 1077, 838, 758, 692; HRMS (FAB): calcd. for C14H21N4 [M+H]
+
 
245.1766, found 245.1768.  
N-Methyl-6-(4-phenyl-1H-1,2,3-triazol-1-yl)hexan-1-amine (4t): white solid 
(124.1 mg, 96%); m.p. 58–60 °C; 
1
H NMR (400 MHz, (CD3)2SO) δ 8.57 (s, 1H), 
7.84 (d, J = 7.5 Hz, 2H), 7.44 (t, J = 7.6 Hz, 2H), 7.32 (t, J = 7.2 Hz, 1H), 4.38 (t, J 
= 7.0 Hz, 2H), 2.39–2.38 (m, 2H), 2.23 (s, 3H), 1.89–1.82 (m, 2H), 1.38–1.26 (m, 
6H); 
13
C NMR (100 MHz, (CD3)2SO) δ 146.2, 130.9, 128.8 (2C), 127.7, 125.0 (2C), 
121.1, 51.4, 49.4, 36.1, 29.6, 29.0, 26.2, 25.8; IR (neat, cm
-1
) υmax 3297, 3118, 3091, 
2925, 2850, 2787, 1462, 1439, 1357, 1215, 1077, 1051, 838, 759, 692; HRMS 
(FAB): calcd. for C15H23N4 [M+H]
+





Azide 7: Prepared according to the previously described procedure in which a 
glycosylation donor was changed to a galactosyl derivative.
30
 TMSI (858 L, 6.03 
mmol) was added to a solution of 1,2,3,4,6-penta-O-trimethylsilyl-α-D-galactose
31
 
(3.26 g, 6.03 mmol) in CH2Cl2 (60 mL) at 0 °C. The reaction mixture was stirred 
under N2 atmosphere for 15 min before benzene (60 mL) was added. The solvent 
was removed under reduced pressure and the glycosyl iodide intermediate obtained 
was dissolved in CH2Cl2 (60 mL) and kept under N2 atmosphere. In a separate flask, 
a mixture of activated 4 Å  molecular sieves (1.50 g), n-Bu4NI (4.47 g, 12.1 mmol), 
i-Pr2NEt (1.58 mL, 9.05 mmol) and (2S,3S,4R)-2-azido-3,4-O-isopropylidene-
1,3,4-octadecanetriol
32
 (770 mg, 2.01 mmol) in CH2Cl2 (60 mL) was prepared and 
stirred under an argon atmosphere at rt for 15 min. The solution of glycosyl iodide 
in CH2Cl2 was then added drop-wise over 5 min and the resulting mixture was 
stirred overnight. After removal of the solvent under reduced pressure, Et2O (60 
mL) and H2O (60 mL) were added and the phases were separated. The organic 
phase was concentrated under reduced pressure. MeOH (60 mL) and PTSA·H2O 
(39.9 mg, 0.21 mmol) were added to the crude mixture and stirred at rt for 5 h. The 
reaction was quenched by the addition of NaHCO3 (300 mg, 3.57 mmol), filtered, 
and then concentrated under reduced pressure. The crude mixture was purified by 
flash column chromatography (CHCl3/MeOH, 6:1) to afford azide 7 (650 mg, 64%, 
α-anomer only) as a white solid. m.p. 195 °C (dec.); [α]
25






H NMR (400 MHz, CDCl3/CD3OD, 2:1) δ 4.69 (d, J = 3.5 Hz, 
1H), 3.90 (dd, J = 10.8 Hz, 3.2 Hz, 1H), 3.75–3.46 (m, 8H), 3.40–3.36 (m, 2H), 
1.42–1.33 (m, 2H), 1.21–1.04 (m, 25H), 0.65 (t, J = 6.6 Hz, 3H); 
13
C NMR (100 
MHz, CDCl3/CD3OD, 2:1) δ 99.2, 73.5, 71.6, 70.5, 69.8, 69.5, 68.4, 67.3, 61.4, 
61.3, 31.8, 31.5, 29.33, 29.26, 29.21, 28.9, 25.4, 22.2, 13.5; IR (neat, cm
-1
) υmax 
3325, 2917, 2851, 2100, 1569, 1469, 1262, 1137, 1065, 1023, 696, 763, 717; 
HRMS (FAB): calcd. for C24H48N3O8 [M+H]
+
 506.3441, found 506.3438. 
α-GalCer analog 5. In a vial fitted with a screw cap, freshly prepared stock 
solutions of CuSO4·5H2O (30 L, 50 mM stock solution in DDW, 1.5 mol%), 
TTTA (1a, 10 L, 50 mM stock solution in CH2Cl2, 0.5 mol%), and sodium 
ascorbate (30 L, 150 mM stock solution in DDW, 4.5 mol%) were added to a 
mixture of 7 (50.5 mg, 0.1 mmol) and 6 (40 mg, 0.11 mmol) in DDW (0.44 mL) 
and CH2Cl2 (0.49 mL). The reaction was allowed to proceed at rt for 2 h. The crude 
reaction mixture was filtered and rinsed with Et2O (10 mL) and DDW (10 mL). 
The resulting solid was dried in vacuo to afford 5 (78.6 mg, 92%) as a white solid. 
m.p. 166–168 °C; [α]
25
D +45.9 (c 0.3, pyridine); 
1
H NMR (400 MHz, C5D5N) δ 
8.28 (s, 1H), 7.07 (d, J = 6.6 Hz, 1H, NH), 6.70 (m, 1H, OH), 6.56 (m, 1H, OH), 
6.51 (m, 1H, OH), 6.43 (d, J = 6.3 Hz, 1H, OH), 6.32 (m, 1H, OH), 5.97 (m, 1H, 
OH), 4.97 (dd, J = 11.5, 4.2 Hz, 1H), 4.69 (dd, J = 11.3, 6.8 Hz, 1H), 4.61 (m, 1H), 




(m, 6H), 1.31–1.25 (m, 63H), 0.86 (t, J = 6.9 Hz, 6H); 
13
C NMR (100 MHz, 
C5D5N) δ 147.8, 122.1, 101.7, 76.7, 73.2, 72.2, 71.5, 71.0, 70.2, 67.4, 62.8, 62.7, 
34.3, 32.1, 30.2, 30.00, 29.96, 29.89, 29.73, 29.62, 29.58, 26.3, 26.2, 22.9, 14.2; IR 
(neat, cm
-1
) υmax 3360, 2916, 2848, 1729, 1464, 1149, 1069, 1029, 794, 719; 
HRMS (FAB): calcd. for C50H98N3O8 [M+H]
+
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국 문 초 록 
 
Part A. 분자 비대칭성 기억 현상과 동적 속도론적 분할 현상을 
이용한 (–)-penibruguieramien A의 비대칭 전합성. 
 
 
(–)-Penibruguieramine A는 해양 pyrrolizidine 알칼로이드로서, 2014년 Guo 
연구진에 의해 중국 맹그로브지대 Bruguiera gymnorrhiza의 식내서성 균류
인 Penicillium sp. GD6 로부터 분리·보고되었다. 이 천연물은 다른 천연물
에서는 보고된 적 없는 흥미로운 골격인 1-hydroxyl-2-methyl pyrrolizidin-
3-one 을 특징적으로 갖고 있어 전합성을 수행하기에 적합한 화합물로 
생각되었다.  
본 논문에서는 proline을 유일한 키랄 소스로 사용하여, ‘분자 비대칭성 
기억 현상 (memory of chirality, MOC)’과 속도론적 분할 현상 (dynamic 
kinetic resolution, DKR)’을 이용한 첫 번째 전합성을 보고하고자 한다. 
MOC와 DKR은 화합물의 비대칭 합성에 있어 유용한 합성 방법이다. 하
지만 천연물의 전합성에 있어 DKR을 활용한 예시들은 보고된 바가 있
지만 MOC를 활용한 예시들은 거의 보고된 바가 없다. 게다가, 이 두 가
지 개념이 조합되어 천연물 혹은 비천연물의 합성에 활용된 바도 알려져 




본 전합성은 천연물에 대해 제안된 생합성 경로를 모방하는 전략을 
사용하였으며, 입체 센터들을 거의 완벽하게 부분 입체, 거울상 입체 선
택적으로 구축하였다. 특히, 매우 높은 수준의 MOC 현상이 양성자성 용
매 하에서 관찰되었는데, 이를 이해하기 위한 기전 연구가 수행되었으며, 
이를 종합하여 전체적인 반응 기전을 제시하였다. 
 
주요어: Aldol reaction, Biomimetic synthesis, Dynamic kinetic resolution, 





국 문 초 록 
 
Part B. 상 전이 촉진제를 이용한 2상 CuAAC 반응 
 
 
기존의 고전적인 Cu(I) catalyzed azide-alkyne 1,3-dipolar 고리화 첨가 반
응 (CuAAC reaction)의 반응 조건은 CuSO4·5H2O와 아스코르브산나트륨의 
반응으로부터 in situ로 생성된 Cu(I) 촉매와 물과 t-BuOH 혼합용매를 사
용했다. 하지만 반응에 사용되는 시약인 Cu(I) 촉매 혹은 그 전구체는 일
반적으로 물에 높은 용해도를 갖는 반면, 기질인 유기 화합물은 물에 낮
은 용해도를 갖는 경우가 많다. 시약과 기질 간 용해성 차이로 인해 고
전적인 CuAAC 반응 조건은 활용 가능한 기질의 폭이 넓지 않았고, 이
런 단점을 극복하기 위해 다양한 반응 조건들이 개발되어왔다.  
 본 논문에서는 상 전이 촉진제를 활용한 2상 CuAAC 반응 조건에 대
해 보고하고자 한다. 물과 유기 용매로 이루어진 2상 용매 시스템은 시
약과 기질의 완전한 용해를 보장한다는 점에서 장점을 갖는다. 수층에서 
CuSO4·5H2O와 아스코르브산나트륨의 반응으로부터 in situ로 생성된 Cu(I) 
촉매는 tris(triazolylmethyl)amine 리간드에 의해서 유기층으로 전이된다. 
이 때에 tris(triazolylmethyl)amine 리간드의 적절한 친수성–소수성 균형이 




으로 전이된 Cu(I)는 반응 기질과 만나 CuAAC 반응을 일으키며, 다양한 
azide, alkyne 기질들이 본 반응 조건에 적합하였다. 특히 일반적인 
CuAAC 반응 조건에 적합하지 않았던 free amino 작용기를 갖고 있는 기
질, 매우 큰 소수성을 나타내는 기질도 본 CuAAC 반응 조건 하에 효율
적으로 반응이 진행되었다.  
 
 
주요어: Click chemistry, Ligand effect, Phase transfer agent, Solvent effect, 
Synthetic method 
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